Hotărâre nr. 223 din 26.03.2024
pentru modificarea Hotărârii Guvernului nr.79/2006 privind aprobarea Listei substanţelor stupefiante, psihotrope şi a plantelor care conţin astfel de substanţe depistate în trafic ilicit, precum şi cantităţile acestora
GUVERNUL REPUBLICII MOLDOVA
H O T Ă R Â R E
pentru modificarea Hotărârii Guvernului nr.79/2006 privind aprobarea
Listei substanţelor stupefiante, psihotrope şi a plantelor care
conţin astfel de substanţe depistate în trafic ilicit,
precum şi cantităţile acestora
nr. 223 din 26.03.2024
(în vigoare 29.03.2024)
Monitorul Oficial al R. Moldova nr.125-129 art. 288 din 29.03.2024
* * *
Guvernul HOTĂRĂŞTE:
1. Hotărârea Guvernului nr.79/2006 privind aprobarea Listei substanţelor stupefiante, psihotrope şi a plantelor care conţin astfel de substanţe depistate în trafic ilicit, precum şi cantităţile acestora (Monitorul Oficial al Republicii Moldova, 2006, nr.16-19, art.106), cu modificările ulterioare, se modifică după cum urmează:
1) denumirea hotărârii va avea următorul cuprins:
"Privind aprobarea Cantităţii substanţelor stupefiante, psihotrope şi a plantelor care conţin astfel de substanţe, depistate în circulaţie ilegală";
2) în partea dispozitivă va avea următorul cuprins:
"Se aprobă Cantitatea substanţelor stupefiante, psihotrope şi a plantelor care conţin astfel de substanţe, depistate în circulaţie ilegală (se anexează).";
3) în anexă:
a) denumirea va avea următorul cuprins:
"CANTITATEA
substanţelor stupefiante, psihotrope şi a plantelor care
conţin astfel de substanţe, depistate în circulaţie ilegală";
b) în capul tabelului, coloana a 2-a, cuvintele "Denumirea substanţei" se substituie cu textul "Denumirea substanţei, plantei";
c) la compartimentul I "Substanţe stupefiante":
poziţia 7 se exclude;
la poziţia 96 în coloana a 2-a, cuvântul "Morferidin" se substituie cu textul "Morferidin (Ethyl 1-[2-(morpholin-4-yl)ethyl]-4-phenylpiperidine-4-carboxylate)";
poziţia 197 se exclude;
se completează cu poziţiile 203-804 cu următorul cuprins:
| "203. | (C7)-CP 47 , 497 sau CP 47 , 497/2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol | 0,001 g | 0,001 g - 0,1 g |
| 204. | JWH-175 3-[(Naphthalen-1-yl)methyl]-1-pentyl-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 205. | MDMB-FUBINACA sau MDMB(N)-Bz-F sau FUB-MDMB/Methyl N-{1-[(4-fluorophenyl) methyl]-1H-indazole-3-carbonyl}-3-methyl-L-valinate | 0,001 g | 0,001 g - 0,1 g |
| 206. | Methamphetamine / N-Methyl-1-phenylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 207. | 1-(2,3,4 - Trimethoxybenzyl)-piperazine dihydrocloride / C14H22N2O3 ˇ 2HCl / 1-(2,3,4 - Trimethoxybenzyl)-piperazine dihydrocloride | 0,001 g | 0,001 g - 0,1 g |
| 208. | 1,3 – Dimethylbutylamine / C6H15N / 1,3 – Dimethylbutylamine sau 1,3-DMBA / DMBA / AMP / 4-amino-2-methylpentane | 0,001 g | 0,001 g - 0,1 g |
| 209. | 1-(2,5 - Dimethoxybenzyl)-piperazine / C13H20N2O2 / 1-[(2,5Dimethoxyphenyl)methyl]piperazine / 1-(2,5-Dimethoxybenzyl)piperazine sau 2,5-DMBP / 2,5-DMBZP | 0,001 g | 0,001 g - 0,1 g |
| 210. | 1- Phenylethylamine / C8H11N / 1-phenylethan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 211. | 1-Phenyl-1-propanamine / C9H13N / 2-(1H-indol-3-yl)-N,N-dipropylacetamide / 1-phenylpropan-1-amine sau alpha-Ethylbenzylamine / 1-Phenylpropylamine | 0,001 g | 0,001 g - 0,1 g |
| 212. | 2-(1H-indol-3-yl)-N,N-dipropylacetamide / C16H22N2O / 2-(1H-indol-3-yl)-N,N-dipropylacetamide | 0,001 g | 0,001 g - 0,1 g |
| 213. | Arecoline / C8H13NO2 / Methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 214. | Bentazepam / C17H16N2OS / 1,3,6,7,8,9-hexahydro-5-phenyl-2H-[1]benzotieno[2,3-e]-1,4-diazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 215. | 4-CIC / C12H16ClNO • HCl / 1-(4-chlorophenyl)-2-(isopropylamino)propan-1-one hydrochloride 4-chloro-N-Isopropylcathinone / 4-Chloroiprcathinone sau Clipredrone | 0,001 g | 0,001 g - 0,1 g |
| 216. | Cyclohexylmethylindole / C15H19N / 1-(cyclohexylmethyl)-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 217. | EPPP / C16H23NO2 / 1-Ethyl-4-phenylpiperidin-4-yl propanoate sau 1-Ethyl-4-phenyl-4-propionoxypiperidine | 0,001 g | 0,001 g - 0,1 g |
| 218. | Ergine / C16H17N3O / 6-Methyl-9,10-didehydroergoline-8β-carboxamide sau (8β)-6-Methyl-9,10-didehydroergoline-8-carboxamide / LA-111 sau d-Lysergamide sau LAA | 0,001 g | 0,001 g - 0,1 g |
| 219. | 4F-NPP / C14H20FNO / 1-(4-fluorophenyl)-2-[(propan-2-yl)amino]pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 220. | 4F-PHP / C16H22FNO / 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 221. | 4-Hydroxymethcathinone / C10H13NO2 / 1-(4-hydroxy-phenyl)-2-methylamino-propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 222. | MDC / C10H11NO3 / 2-Amino-1-(1,3-benzodioxol-5-yl)propan-1-one sau 3,4-Methylenedioxycathinone / bk-MDA | 0,001 g | 0,001 g - 0,1 g |
| 223. | 4-MeO-PV9 / C19H29NO2 / 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)octan-1-one sau 4-MeO-alpha-POP, 4-MeO-α-PV9 | 0,001 g | 0,001 g - 0,1 g |
| 224. | N-(2,6-Dimethylphenyl)-1- piperidineacetamide / C15H22N2O / N-(2,6-Dimethylphenyl)-1-piperidineacetamide | 0,001 g | 0,001 g - 0,1 g |
| 225. | N-Benzyl-1-phenylethylamine / C15H17N / N-benzyl-1-phenylethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 226. | N Propyl–3,4–methylenedioxycathinone/ Propilone / C13H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one sau Propyl–3,4–methylenedioxycathinone | 0,001 g | 0,001 g - 0,1 g |
| 227. | Pentylindole / C13H17N / 1-Pentyl-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 228. | Phenmetetrazine / C13H19NO / 4-ethyl-3-methyl-2-phenylmorpholine | 0,001 g | 0,001 g - 0,1 g |
| 229. | 3-Methylphenmetrazine / C12H17NO / 3-methyl-2-(3-methylphenyl)morpholine sau 3-Methylphenmetrazine, 3-MPM, 3-MPH | 0,001 g | 0,001 g - 0,1 g |
| 230. | Phenmetrazine / C11H15NO / 2-phenyl-3-methylmorpholine sau Oxazimedrine | 0,001 g | 0,001 g - 0,1 g |
| 231. | Isophenmetrazine / C11H15NO / 5-methyl-2-phenylmorpholine | 0,001 g | 0,001 g - 0,1 g |
| 232. | Prolintane / C15H23N / 1-(1-Benzylbutyl)pyrrolidine | 0,001 g | 0,001 g - 0,1 g |
| 233. | RH – 34 / C18H19N3O3 / 3-{2-[(2-methoxybenzyl)amino]ethyl}quinazoline-2,4(1H,3H)-dione | 0,001 g | 0,001 g - 0,1 g |
| 234. | Thiopropamine / C7H11NS / α-methyl-2-thiopheneethanamine sau Thienoamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 235. | 1P-LSD (sugativă, timbru) / C23H29N3O2 / N,N-Diethyl-6-methyl-1-propanoyl-9,10-didehydroergoline-8β-carboxamide sau 1-propionyl-lysergic acid diethylamide | 0,001 g | 0,001 g - 0,1 g |
| 236. | 4-fluoroamphetamine / 4 – FA (pulbere/lichid) / C9H12FN / 1-(4-Fluorophenyl)propan-2-amine sau 4-FMP, PFA para-fluoroamphetamine | 0,001 g 0,02 ml |
0,001 g - 0,1 g 0,02 ml – 2 ml |
| 237. | 3-FEA / 3-Fluoroethamphetamine / C11H16FN / 2-(Furan-3-yl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 238. | 5-MeO-MiPT (pulbere) / C15H22N2O / 5-methoxy-N-methyl-N-isopropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 239. | 6-APB ( pulbere/tablete) / C11H13NO / 6-(2-aminopropyl)benzofuran | 0,001 g | 0,001 g - 0,1 g |
| 240. | 5-APB / C11H13NO / 5-(2-Aminopropyl)benzofuran | 0,001 g | 0,001 g - 0,1 g |
| 241. | Acrylfentanyl (pulbere) / C22H26N2O / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide | 0,001 g | 0,001 g - 0,1 g |
| 242. | ADB – CHMINACA / MAB-CHMINACA / C21H30N4O2 / N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 243. | alpha-pyrrolidinohexanophenone / alpha-PHP (pulbere) / C16H23NO / 1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one sau PV-7 | 0,001 g | 0,001 g - 0,1 g |
| 244. | Furanylfentanyl (pulbere, spray, capsule/tablete) / C24H26N2O2 / N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide sau FU-F, 2-furanylfentanyl | 0,001 g 0,02 ml |
0,001 g - 0,1 g 0,02 ml – 2 ml |
| 245. | THF-F / C24H30N2O2 / N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide sau THF-fentanyl, Tetrahydrofuranylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 246. | GHB/ gamma-hydroxybutyrate (lichid) / C4H8O3 / 4-Hydroxybutanoic acid sau γ-Hydroxybutyric acid | 0,001 g 0,02 ml |
0,001 g - 0,1 g 0,02 ml – 2 ml |
| 247. | Mexedrone (pulbere) / C12H17NO2 / 3-methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 248. | NEDPA/ Ephenidine (pulbere) / C16H19N / N-ethyl-1,2-diphenylethan-1-amine sau EPE | 0,001 g | 0,001 g - 0,1 g |
| 249. | THJ-018 (pulbere) / C23H22N2O / 3-(naphthalene-1-carbonyl)-1-pentyl-1H-indazole | 0,001 g | 0,001 g - 0,1 g |
| 250. | 5F-THJ-018 / C22H21FN4O / 1-(5-fluoropentyl)-3-(naphthalene-1-carbonyl)-1H-indazole sau THJ-2201 (AM-2201 indazole analogue) | 0,001 g | 0,001 g - 0,1 g |
| 251. | TH-PVP (cristale) / C19H27NO / 2-(Pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one sau 3',4'-tetramethylene- a-PVP | 0,001 g | 0,001 g - 0,1 g |
| 252. | alpha-POP / PV9 (pulbere) / C18H27NO / 1-Phenyl-2-(pyrrolidin-1-yl)octan-1-one sau α-Pyrrolidino-octanophenone | 0,001 g | 0,001 g - 0,1 g |
| 253. | Pentylone (pulbere) / C13H17NO3 / β-Keto-Methylbenzodioxolylpentanamine sau βk-Methyl-K, βk-MBDP, methylenedioxypentedrone | 0,001 g | 0,001 g - 0,1 g |
| 254. | Ocfentanyl/ Ocfentanil (pulbere) / C22H27FN2O2 / (4-benzylpiperazin-1-yl)(2-(isopentylamino)pyridin-3-yl)methanone sau 2-fluoro MAF, o-fluoro MAF, 2-fluoro Methoxyacetyl fentanyl | 0,001 g | 0,001 g - 0,1 g |
| 255. | 4-ANPP, ANPP/ Despropionylfentanyl / C19H24N2 / N-phenyl-1-(2-phenylethyl)piperidin-4-amine sau 4-anilino-N-phenethylpiperidine | 0,001 g | 0,001 g - 0,1 g |
| 256. | N-ethylhexedrone/ NEH (pulbere) / C14H21NO / 2-(ethylamino)-1-phenylhexan-1-one sau HEXEN | 0,001 g | 0,001 g - 0,1 g |
| 257. | 2-MeO-diphenidine / MXP (pulbere) / C20H25NO / 1-[1-(2-Methoxyphenyl)-2-phenylethyl]piperidine sau Methoxphenidine, 2-MXD | 0,001 g | 0,001 g - 0,1 g |
| 258. | JWH-210 (pulbere/substanţă solidă) / C26H27NO / (4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 259. | Isopropylphenidate (pulbere) / C16H23NO2 / Propan-2-yl phenyl(piperidin-2-yl)acetate sau IPH, IPPD | 0,001 g | 0,001 g - 0,1 g |
| 260. | Flubromazepam / C15H10BrFN2O / 7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 261. | Phenyl-2-nitropropene (pulbere) / C9H9NO2 / (2-nitro-1-propen-1-yl)-benzene sau P2NP | 0,001 g | 0,001 g - 0,1 g |
| 262. | N-ethylnorpentedrone / Ethylpentylone (tablete) / C13H19NO / 2-(Ethylamino)-1-phenylpentan-1-one sau N-ethlyaminopentiophenone, Ethylpentylone | 0,001 g | 0,001 g - 0,1 g |
| 263. | N,N-Diethylpentylone / C16H23NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(diethylamino)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 264. | O-PCE / Eticyclidone sau 2-(Ethylamino)-2-phenylcyclohexan-1-one sau 2'-oxo-PCE | 0,001 g | 0,001 g - 0,1 g |
| 265. | diButylone / bk-DMBDB / C13H17NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one sau Methylbutylone | 0,001 g | 0,001 g - 0,1 g |
| 266. | alpha-PEP/ PV8 (pulbere) / C17H25NO / 1-Phenyl-2-(pyrrolidin-1-yl)heptan-1-one sau α-PHPP | 0,001 g | 0,001 g - 0,1 g |
| 267. | MDPEP / C18H25NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)heptan-1-one sau 3,4-methylenedioxy-PV8 | 0,001 g | 0,001 g - 0,1 g |
| 268. | AMB-CHMICA (pulbere) / C22H30N2O3 / Methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]-L-valinate sau MMB-CHMICA | 0,001 g | 0,001 g - 0,1 g |
| 269. | alpha-PiHP (pulbere) / C16H23NO / 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 270. | 5-MeO-DMT (pulbere) / C13H18N2O / 2-(5-Methoxy-1H-indol-3-yl)-N,N-dimethylethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 271. | 5F-AB-FUPPYCA (pulbere) / C20H26F2N4O2 / N2-[1-(5-Fluoropentyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carbonyl]-L-valinamide sau AZ-037 | 0,001 g | 0,001 g - 0,1 g |
| 272. | 4F-MPH / (pulbere) / C14H18FNO2 / Methyl (4-fluorophenyl)(piperidin-2-yl)acetate sau 4-fluoromethylphenidate | 0,001 g | 0,001 g - 0,1 g |
| 273. | 4F-EPH / 4-fluoroethylphenidate (pulbere) / C15H20FNO2 / Ethyl (4-fluorophenyl)(piperidin-2-yl)acetate | 0,001 g | 0,001 g - 0,1 g |
| 274. | 4-Phenylpiperidine (pulbere) | 0,001 g | 0,001 g - 0,1 g |
| 275. | 4-EMC / 4-Ethylmethcathinone (pulbere) / C12H17NO / 1-(4-Ethylphenyl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 276. | 4-AcO-DMT (pulbere) / C14H18N2O2 / 4-acetoxy-N,N-dimethyltryptamine sau Psilacetin, O-Acetylpsilocin | 0,001 g | 0,001 g - 0,1 g |
| 277. | 3-MeO-PCP (tablete) / C18H27NO / 1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine sau 3-Methoxyphencyclidine | 0,001 g | 0,001 g - 0,1 g |
| 278. | 3-fluorophenmetrazine/ 3-FPM (pulbere, cristale) / C11H14FNO / 2-(3-fluorophenyl)-3-methylmorpholine sau 3-FPH, PAL-593 | 0,001 g | 0,001 g - 0,1 g |
| 279. | 3,4-dichloromethylphenidate (pulbere) / C14H17Cl2NO2 / Methyl (3,4-dichlorophenyl)(piperidin-2-yl)acetate sau 3,4-DCMP | 0,001 g | 0,001 g - 0,1 g |
| 280. | 2-FA (pulbere) / C9H12FN / 1-(2-Fluorophenyl)propan-2-amine sau 2- fluoroamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 281. | 2C-B-fly (tablete) / C12H14BrNO2 / 2-(8-bromo-2,3,6,7-tetrahydrofuro [2,3-f][1] benzofuran-4-yl)ethanamine | 0,001 g | 0,001 g - 0,1 g |
| 282. | 3C-B-fly / C13H16BrNO2 / 1-(8-bromo-2,3,6,7-tetrahydrobenzo[2,3-f][1]benzofuran-4-yl)-propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 283. | 2C-B (Nexus) (tablete, capsule) / C10H14BrNO2 / 2,5-dimethoxy-4-bromophenethylamine sau BDMPEA | 0,001 g | 0,001 g - 0,1 g |
| 284. | MXE / Methoxetamine (pulbere) / C15H21NO2/ 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one sau 3-MeO-2'-oxo-PCE | 0,001 g | 0,001 g - 0,1 g |
| 285. | 3,4-CTMP (pulbere) / C14H17Cl2NO2 / N-methyl-2,3-dihydro-1H-inden-2-amine sau 3,4-dichloromethylphenidate | 0,001 g | 0,001 g - 0,1 g |
| 286. | N-methyl-2AI / NM-2AI / C10H13N / N-methyl-2,3-dihydro-1H-inden-2-amine sau N-methyl-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 287. | 5-IAI / C9H10IN / 5-Iodo-2,3-dihydro-1H-inden-2-amine sau 5-Iodo-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 288. | MDAI / C10H11NO2 / 2H,5H,6H,7H-indeno[5,6-d][1,3]dioxol-6-amine sau 5,6-methylenedioxy-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 289. | MDMAI / C11H13NO2 / N-Methyl-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine sau 5,6-Methylenedioxy-N-methyl-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 290. | 1-Aminoindane / C9H11N / 2,3-dihydro-1H-inden-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 291. | 2-Aminoindane / 2-AI / C9H11N / 2,3-dihydro-1H-inden-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 292. | MMAI / C11H15NO / 5-Methoxy-6-methyl-2,3-dihydro-1H-inden-2-amine sau 5-Methoxy-6-methyl-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 293. | ETAI / C12H14F3N / N-Ethyl-5-(trifluoromethyl)-2,3-dihydro-1H-inden-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 294. | Methamnetamine / C14H17N/ N-Methyl-1-(naphthalen-2-yl)propan-2-amine sau Methylnaphetamine, MNA, MNT, PAL-1046 | 0,001 g | 0,001 g - 0,1 g |
| 295. | 5-APB NBOMe / C19H21NO2 / 1-(benzofuran-5-yl)-N-(2-methoxybenzyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 296. | 2-EAPB sau 1-(1-Benzofuran-2-yl)-N-ethylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 297. | 2-APB / C11H13NO / 2-(2-aminopropyl)benzofuran | 0,001 g | 0,001 g - 0,1 g |
| 298. | 2-MAPB / C12H15NO / 1-(1-Benzofuran-2-yl)-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 299. | 6-EAPB / C13H17NO / 1-(benzofuran-6-yl)-N-ethylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 300. | 6-MAPB / C12H15NO / 1-(1-Benzofuran-6-yl)-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 301. | bk-MPA / C8H11NOS / 2-(Methylamino)-1-(thiophen-2-yl)propan-1-one sau MTP, Thiothinone | 0,001 g | 0,001 g - 0,1 g |
| 302. | 5Cl-bk-MPA / C8H10ClNOS / 1-(5-Chlorothiophen-2-yl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 303. | 5-EAPB / C13H17NO / 1-(Benzofuran-5-yl)-N-ethylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 304. | alpha-PVT / C13H19NOS / 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one sau α-Pyrrolidinopentiothiophenone | 0,001 g | 0,001 g - 0,1 g |
| 305. | 5-APDI / C12H17N / 5-(2-Aminopropyl)-2,3-dihydro-1H-indene sau Indanylaminopropane, IAP | 0,001 g | 0,001 g - 0,1 g |
| 306. | 5-APDB / C11H15NO / 1-(2,3-Dihydro-1-benzofuran-5-yl)propan-2-amine sau 3-Desoxy-MDA, EMA-4 | 0,001 g | 0,001 g - 0,1 g |
| 307. | 6-APDB / C11H15NO / 1-(2,3-Dihydro-1-benzofuran-6-yl)propan-2-amine sau 4-Desoxy-MDA, EMA-3 | 0,001 g | 0,001 g - 0,1 g |
| 308. | Thienoamphetamine/ C7H11NS / 1-(2Thienyl)propan-2-amine, 1-Methyl-2-thiophen-2-yl-ethylamine | 0,001 g | 0,001 g - 0,1 g |
| 309. | 2-Phenyl-3-aminobutane / 2-Phenyl-3-aminobutane, 3-Phenyl-2-butanamine sau β-methylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 310. | 4-APB / C11H13NO / 1-Benzofuran-4-yl-propan-2-amine sau 4-(2-Aminopropyl)benzofuran | 0,001 g | 0,001 g - 0,1 g |
| 311. | DPIA / C19H25N / 1-Phenyl-N-(1-phenylpropan-2-yl)propan-2-amine sau di-(B-phenylisopropyl)amine | 0,001 g | 0,001 g - 0,1 g |
| 312. | N-formyl-DPIA / C19H23NO / | 0,001 g | 0,001 g - 0,1 g |
| 313. | 3MeO-PCMo / C17H25NO2 / 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine | 0,001 g | 0,001 g - 0,1 g |
| 314. | 3MeO-PCP / 3-Methoxyphencyclidine / C18H27NO / 1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine | 0,001 g | 0,001 g - 0,1 g |
| 315. | Deschloroketamine / DCK / C13H17NO / 2-(Methylamino)-2-phenylcyclohexan-1-one sau DXE, 2'-Oxo-PCM | 0,001 g | 0,001 g - 0,1 g |
| 316. | N-ethylnorketamine / C14H18ClNO / 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 317. | 2-MeO-Ketamine / Methoxyketamine / C14H19NO2 / 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexan-1-one sau 2-MeO-2-deschloroketamine | 0,001 g | 0,001 g - 0,1 g |
| 318. | 4-MeO-PCP / 4-Methoxyphencyclidine / C18H27NO / 1-[1-(4-Methoxyphenyl)cyclohexyl]piperidine sau Methoxydine | 0,001 g | 0,001 g - 0,1 g |
| 319. | 3-MeO-PCE / 3-Methoxyeticyclidine / C15H23NO / N-Ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 320. | Nifoxipam / C15H10FN3O4 / 5-(2-Fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 321. | Clonazolam / Clonitrazolam/ C17H12ClN5O2 / | 0,001 g | 0,001 g - 0,1 g |
| 322. | Flubromazolam / C17H12BrFN4 / 8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | 0,001 g | 0,001 g - 0,1 g |
| 323. | Deschloroetizolam / C17H16N4S / 2-Ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine sau Thiénalprazolam | 0,001 g | 0,001 g - 0,1 g |
| 324. | Diclazepam / chlorodiazepam / C16H12Cl2N2O / 7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one sau 2'-chloro-diazepam | 0,001 g | 0,001 g - 0,1 g |
| 325. | Pyrazolam / C16H12BrN5 / 8-Bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | 0,001 g | 0,001 g - 0,1 g |
| 326. | AMB-CHMICA / C22H30N2O3 / Methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]-L-valinate sau MMB-CHMICA | 0,001 g | 0,001 g - 0,1 g |
| 327. | MDMB-CHMCZCA / C27H34N2O3 / Methyl N-[9-(cyclohexylmethyl)-9H-carbazole-3-carbonyl]-3-methyl-L-valinate, Methyl (2S)-2-{[9-(cyclohexylmethyl)-9H-carbazole-3-carbonyl]amino}-3,3-dimethylbutanoate | 0,001 g | 0,001 g - 0,1 g |
| 328. | AB-CHMFUPPYCA / C22H29FN4O2 / N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide sau AB-CHFUPYCA | 0,001 g | 0,001 g - 0,1 g |
| 329. | CBL-018 / C24H23NO2 / Naphthalen-1-yl 1-pentyl-1H-indole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 330. | 5-fluoropentyl-3-pyridinoylindole / C19H19FN2O / [1-(5-Fluoropentyl)-1H-indol-3-yl](phenyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 331. | 5F-PY-PICA / C18H23FN2O / [1-(5-Fluoropentyl)-1H-indol-3-yl](pyrrolidin-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 332. | FUB-JWH-018 / C26H18FNO / {1-[(4-Fluorophenyl)methyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone sau FUB-018 | 0,001 g | 0,001 g - 0,1 g |
| 333. | 5C-AKB48 / C23H30ClN3O / N-(Adamantan-1-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide sau 5Cl-AKB-48 | 0,001 g | 0,001 g - 0,1 g |
| 334. | 5F-EMB-PINACA / C20H28FN3O3 / Ethyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate sau 5F-AEB | 0,001 g | 0,001 g - 0,1 g |
| 335. | 5F-PY-PINACA / C17H22FN3O / [1-(5-Fluoropentyl)-1H-indazol-3-yl](pyrrolidin-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 336. | EMB-FUBINACA / C20H28FN3O3 / Ethyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate sau AEB-FUBINACA, FUB-AEB | 0,001 g | 0,001 g - 0,1 g |
| 337. | MDMB-FUBICA / C23H25FN2O3 / Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}amino)-3,3-dimethylbutanoate | 0,001 g | 0,001 g - 0,1 g |
| 338. | AMB-CHMINACA / C21H29N3O3 / Methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate sau MMB-CHMINACA, MA-CHMINACA | 0,001 g | 0,001 g - 0,1 g |
| 339. | SDB-005 / C23H22N2O2 / naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 340. | 5F-ADB-PINACA / C19H27FN4O2 / N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 341. | ADB-PINACA / C19H28N4O2 / N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 342. | AB-PINACA N-(2-fluoropentyl) isomer / C18H25FN4O2 / N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazole-3-carboxamide sau 2-fluoro AB-PINACA | 0,001 g | 0,001 g - 0,1 g |
| 343. | 5Cl-AB-PINACA / C18H25ClN4O2 / 2-{[1-(5-chloropentyl)-1H-indazol-3-yl]formamido}-3-methylbutanamide sau 5Cl-ABP | 0,001 g | 0,001 g - 0,1 g |
| 344. | APP-CHMINACA / C24H28N4O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide sau PX-3 | 0,001 g | 0,001 g - 0,1 g |
| 345. | APP-FUBINACA / C24H21FN4O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 346. | MDMB-FUBINACA / C22H24FN3O3 / Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3,3-dimethylbutanoate sau FUB-MDMB, MDMB(N)-Bz-F | 0,001 g | 0,001 g - 0,1 g |
| 347. | CUMYL-5F-P7AICA / C22H26FN3O / (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-7-azaindole- 3-carboxamide) sau SGT-263 | 0,001 g | 0,001 g - 0,1 g |
| 348. | M-CHMIC / C17H21NO2 / methyl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 349. | FUB-144 / C23H24FNO / {1-[(4-Fluorophenyl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone sau FUB-UR-144 | 0,001 g | 0,001 g - 0,1 g |
| 350. | 5F-MDMB-PINACA / C20H28FN3O3 / Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate sau 5F-ADB, MDMB(N)-2201 | 0,001 g | 0,001 g - 0,1 g |
| 351. | ADAMANTYL-THPINACA / C24H31N3O2 / N-(Adamantan-1-yl)-1-[(oxan-4-yl)methyl]-1H-indazole-3-carboxamide sau ATHPINACA, AD-THPINACA | 0,001 g | 0,001 g - 0,1 g |
| 352. | 5F-AMB-PICA / C20H27FN2O3 / Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indole-3-carbonyl]amino}-3-methylbutanoate sau MMB-2201, I-AMB | 0,001 g | 0,001 g - 0,1 g |
| 353. | 5F-APP-PINACA / C22H25FN4O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide sau PX-2, FU-PX, PPA(N)-2201 | 0,001 g | 0,001 g - 0,1 g |
| 354. | APP-FUBINACA / C24H21FN4O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 355. | 5F-APP-PICA / C23H26FN3O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(5-fluoropentyl)-1H-indole-3-carboxamide sau PX-1, SRF-30 | 0,001 g | 0,001 g - 0,1 g |
| 356. | ADB-CHMICA / C22H31N3O2 / N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 357. | CUMYL-5FPINACA / C22H26FN3O / 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 358. | NM-2201 / C24H22FNO2 / Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate sau CBL-2201 | 0,001 g | 0,001 g - 0,1 g |
| 359. | 5F-SDB-005 / C23H21FN2O2 / naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 360. | ADB-CHMINACA / C21H30N4O2 / N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide sau N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide sau MAB-CHMINACA | 0,001 g | 0,001 g - 0,1 g |
| 361. | CUMYL-BICA / C22H27N3O / 1-Butyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide sau SGT-24 | 0,001 g | 0,001 g - 0,1 g |
| 362. | CUMYL-PINACA / C22H27N3O / 1-Pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 363. | 4Cl-CUMYL-PINACA / C22H26ClN3O / N-[2-(4-chlorophenyl)propan-2-yl]-1-pentyl-1H-indazole-3-carboxamide sau SGT-157 | 0,001 g | 0,001 g - 0,1 g |
| 364. | CUMYL-5F-PICA / C23H27FN2O / 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 365. | CUMYL-THPINACA / C23H27N3O2 / 1-[(Oxan-4-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide sau SGT-42 | 0,001 g | 0,001 g - 0,1 g |
| 366. | CUMYL-PICA / C23H28N2O / 1-Pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide sau SGT-56 | 0,001 g | 0,001 g - 0,1 g |
| 367. | AB-FUBINACA 2-fluorobenzyl isomer / C20H21FN4O2 / N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(2-fluorophenyl)methyl]-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 368. | MN-18 / C23H23N3O / N-(naphthalen-1-yl)-1-pentyl-1H-indazol-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 369. | 5F- MN-18 / C23H22FN3O / 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 370. | FUB-AKB48 / C25H26FN3O / N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide sau FUB-APINACA, AFUBINACA | 0,001 g | 0,001 g - 0,1 g |
| 371. | 5F-AKB-57 / C23H29FN2O2 / adamantan-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate sau 5-flouro-APINAC | 0,001 g | 0,001 g - 0,1 g |
| 372. | JWH-071 / C21H17NO / (1-Ethyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 373. | EG-018 / C28H25NO / (Naphthalen-1-yl)(9-pentyl-9H-carbazol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 374. | AM-2201 sau [1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 375. | FUBIMINA / C23H21FN2O / [1-(5-Fluoropentyl)-1H-benzimidazol-2-yl](naphthalen-1-yl)methanone sau BIM-2201, BZ-2201, FTHJ | 0,001 g | 0,001 g - 0,1 g |
| 376. | 5F-AMBICA / C19H26FN3O3 / N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 377. | FDU-PB-22 / C26H18FNO2 / Naphthalen-1-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 378. | Mepirapim / C19H27N3O / (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 379. | PB-22 indazole analogue / C22H21N3O2 / 1-pentyl-1H-indazole-3-carboxylic acid, 8-quinolinyl ester sau NPB-22 | 0,001 g | 0,001 g - 0,1 g |
| 380. | 5F- NPB-22 / 5F-QUP7AIC / C22H20FN3O2 / quinolin-8-yl 1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 381. | M5FPIC / C15H18FNO2 / methyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate sau 5F-PB-22 methylester analogue | 0,001 g | 0,001 g - 0,1 g |
| 382. | N,N-Diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine / C21H29N3S/ N-ethyl-N-((2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl)methyl)ethanamine | 0,001 g | 0,001 g - 0,1 g |
| 383. | N-1-Naphthalenyl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide / C23H22FN3O / 1-(5-Fluoropentyl)-N-1-naphthalenyl-1H-indazole-3-carboxamide sau 5F-MN-18 | 0,001 g | 0,001 g - 0,1 g |
| 384. | N-(2-Methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine / C23H33N3OS / N-(2-methoxyethyl)-N-((2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl)methyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 385. | 1-(Cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazol-5-carboxamide / C28H37N3O2 / 1-(Cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazol-5-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 386. | A-796,260 isomer / C22H30N2O2 / (E)-3,4,4-trimethyl-1-(1-(2-morpholinoethyl)-1H-indol-3-yl)pent-2-en-1-one | 0,001 g | 0,001 g - 0,1 g |
| 387. | SDB-006 / C21H24N2O / N-Benzyl-1-pentyl-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 388. | 5F-SDB-006 / C21H23FN2O / N-Benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 389. | FUB-PB-22 / C25H17FN2O2 / Quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 390. | AM-6527 5-fluoropentyl derivat / C24H23FN2O / (N-5-fluoropentyl) (1-(5-Fluoropentyl)-N-(napthalen-2-yl)-1H-indole-3-carboxamide) sau 5F-NNEI-2 | 0,001 g | 0,001 g - 0,1 g |
| 391. | MN-24 / C24H24N2O / N-(Naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide sau NNEI, AM-6527 | 0,001 g | 0,001 g - 0,1 g |
| 392. | AM-2201 indazole / C23H21FN2O / [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone sau THJ-2201, 5-Fluoro-THJ-018 | 0,001 g | 0,001 g - 0,1 g |
| 393. | AM-2201 N-(4-fluoropentyl) / C24H22FNO / (1-(4-fluoropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 394. | MAM-2201 / C25H24FNO / [1-(5-Fluoropentyl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone sau JWH-122 (5-fluoropentyl), AM-2201 4-methylnaphthyl analog | 0,001 g | 0,001 g - 0,1 g |
| 395. | ADBICA / C20H29N3O2 / N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide sau ADB-PICA | 0,001 g | 0,001 g - 0,1 g |
| 396. | LY2183240-2'-isomer / C17H17N5O / 5-([1,1'-biphenyl]-4-ylmethyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 397. | ADB-PINACA / C19H28N4O2 / N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 398. | 5F-ADB-PINACA / C19H27FN4O2 / N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 399. | 5F-ADBICA / C20H28FN3O2 / N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 400. | AM-1248 Azepane isomer / C26H34N2O / (3,5,7)-adamantan-1-yl(1-(1-methylazepan-3-yl)-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 401. | JWH-412 5-fluoropentyl / C24H21F2NO / (4-fluoro-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone sau JWH 412 5-fluoropentyl analog, 5-fluoro JWH 412 | 0,001 g | 0,001 g - 0,1 g |
| 402. | JTE-907 / C24H26N2O6 / N-(Benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 403. | A-836,339 / C16H26N2O2S / N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 404. | JWH-307 bromo derivative / C26H24BrNO / (5-(2-bromophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 405. | JWH-030 / C24H22BrNO / Naphthalen-1-yl-(1-pentylpyrrol- 3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 406. | JWH-145 / C26H25NO / 1-Naphthalenyl(1-pentyl-5-phenyl-1H-pyrrol-3-yl)-methanone | 0,001 g | 0,001 g - 0,1 g |
| 407. | UR-144 (N-heptyl analogue) / UR-144 heptyl derivat / C23H33NO / (1-Heptyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 408. | UR-144 / C21H29NO / (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone sau TMCP-018, MN-001 | 0,001 g | 0,001 g - 0,1 g |
| 409. | JWH-368 / C26H24FNO / [5-(3-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | 0,001 g | 0,001 g - 0,1 g |
| 410. | EAM-2201 / C26H26FNO / (1-(5-Fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone sau 5-Fluoro JWH-210, 4'-ethyl-AM-2201 | 0,001 g | 0,001 g - 0,1 g |
| 411. | JWH-methylcyclohexane-8quinolinol / BB-22 / C25H24N2O2 / 8-Quinolinyl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate sau QUCHIC | 0,001 g | 0,001 g - 0,1 g |
| 412. | A-834,735 / C22H29NO2 / 1-(Tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 413. | 5Cl-UR-144 / C21H28ClNO / (1-(5-Chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone sau UR-144 N-(5-chloropentyl) | 0,001 g | 0,001 g - 0,1 g |
| 414. | AB-005 / C23H32N2O / 1-[(1-methylpiperidin-2-yl)methyl]-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 415. | AB-005 azepane isomer / C23H32N2O / 1-(1-methylazepan-2-yl)-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 416. | 4-HTMPIPO / C21H31NO2 / 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 417. | JWH-302 / C22H25NO2 / (1-pentyl-3-(3-methoxyphenylacetyl)indole) | 0,001 g | 0,001 g - 0,1 g |
| 418. | JWH 018 N-(5-chloropentyl) derivative / C24H22ClNO / (1-(5-chloropentyl)-1H-indol-3-yl)(naphthalene-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 419. | JWH 018 N-(5-bromopentyl) derivative / C24H22ClNO / [1-(5-bromopentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 420. | JWH-018 adamantyl carboxamide / APICA / C24H32N2O / N-(Adamantan-1-yl)-1-pentyl-1H-indole-3-carboxamide sau 2NE1, SDB-001 | 0,001 g | 0,001 g - 0,1 g |
| 421. | JWH-018 (cyclohexylmethyl) / C26H25NO / (1-(cyclohexylmethyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 422. | JWH-018 N-(5-hydroxypentyl) / C24H23NO2 / (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 423. | JWH-018 (5-chloropentyl) indazole analogue / C23H21ClN2O / 5Cl-THJ-018 | 0,001 g | 0,001 g - 0,1 g |
| 424. | MAM-2201 chloropentyl derivat / C25H24ClNO / [1-(5-chloropentyl)-1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone | 0,001 g | 0,001 g - 0,1 g |
| 425. | JWH-122 pentenyl 2-methylindole derivat / C26H25NO / (2-methyl-1-(pent-4-en-1-yl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 426. | JWH-122 (5-Methyl-naphtyl isomer) /C25H25NO / | 0,001 g | 0,001 g - 0,1 g |
| 427. | AM-694 methyl substituent de iod / C21H22FNO / (1-(5-fluoropentyl)-1H-indol-3-yl)(o-tolyl)methanone sau 1-(5-fluoropentyl)-3-(2-methylbenzoyl)indole | 0,001 g | 0,001 g - 0,1 g |
| 428. | AM-694 ethyl substituent de iod / C22H24FNO / 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-ethylphenyl)methanone sau 1-(5-fluoropentyl)-3-(2-ethylbenzoyl)indole | 0,001 g | 0,001 g - 0,1 g |
| 429. | UR-144 (-2H) sau 1-pentyl-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indole sau KM X-1, TMCP-018, MN-001 | 0,001 g | 0,001 g - 0,1 g |
| 430. | STS-135 / C24H31FN2O / N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide sau 5F-APICA | 0,001 g | 0,001 g - 0,1 g |
| 431. | JWH-370 / C27H27NO / [5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | 0,001 g | 0,001 g - 0,1 g |
| 432. | 3-(p-Methoxybenzoyl)-N-methylindole | 0,001 g | 0,001 g - 0,1 g |
| 433. | URB-754 / C16H14N2O2 / 6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one | 0,001 g | 0,001 g - 0,1 g |
| 434. | HU-331 / C21H28O3 / 3-hydroxy-2-[(1R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylcyclohexa-2,5-diene-1,4-dione | 0,001 g | 0,001 g - 0,1 g |
| 435. | AM-679 / C20H20INO / 2-iodophenyl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 436. | WIN 55212-2 / C27H26N2O3 / (R)-(+)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl( naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 437. | AM-2232 / C24H20N2O / 5-[3-(1-naphthoyl)-1H-indol-1-yl]pentanenitrile | 0,001 g | 0,001 g - 0,1 g |
| 438. | AM-694 chloro derivat / C20H19ClINO / 1-(5-chloropentyl)-1H-indol-3-yl(2-iodophenyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 439. | JWH-022 / C24H21NO / naphthalen-1-yl[1-(pent-4-en-1-yl)-1H-indol-3-yl]methanone | 0,001 g | 0,001 g - 0,1 g |
| 440. | JWH-387 / C24H22BrNO / 4-bromonaphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 441. | JWH-412 / C24H22FNO / 4-fluoronaphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 442. | JWH-071 / C21H17NO / (1-ethyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 443. | JWH-073 / C23H21NO / (1-butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 444. | JWH-081 / C25H25NO2 / JWH-081(4-Methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone | 0,001 g | 0,001 g - 0,1 g |
| 445. | AM-2233 / C22H23IN2O / 2-iodophenyl[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]methanone | 0,001 g | 0,001 g - 0,1 g |
| 446. | Org 27569 / C24H28CIN3O / 5-Chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide | 0,001 g | 0,001 g - 0,1 g |
| 447. | Org 27759 / C21H24FN3O / N-{2-[4-(dimethylamino)phenyl]ethyl}-3-ethyl-5-fluoro-1H-indole-2-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 448. | Org 29647 / C22H24CIN3O / N-(1-benzylpyrrolidin-3-yl)-5-chloro-3-ethyl-1H-indole-2-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 449. | RCS-4-C4 homolog/ RSC-4 (C4) / C20H21NO2 / 1-butyl-1H-indol-3-yl(4-methoxyphenyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 450. | RCS-4 / C21H23NO2 / 4-methoxyphenyl(1-pentyl-1H-indol-3-yl)methanone sau SR-19, BTM-4, E-4 | 0,001 g | 0,001 g - 0,1 g |
| 451. | AM-1220 / C26H26N2O / 1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl (naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 452. | AM-1220 azepane isomer / C26H26N2O / 1-(1-methylazepan-3-yl)-1H-indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 453. | JWH-007 / C25H25NO / 2-methyl-1-pentyl-1H-indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 454. | WIN 48,098 / Pravadoline / C23H26N2O3 / (4-Methoxyphenyl)[(2-methyl)-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-methanone sau WIN 48098-6 | 0,001 g | 0,001 g - 0,1 g |
| 455. | RCS-4 ortho isomer / C21H23NO2 / 2-methoxyphenyl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 456. | JWH-018 adamantyl derivat / AB-001 / C24H31NO / adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone sau 1-pentyl-3-(1-adamantoyl)indole JWH-018 adamantoyl derivat | 0,001 g | 0,001 g - 0,1 g |
| 457. | JWH-251 / C22H25NO / 2-(2-methylphenyl)-1-(1-pentylindol-3-yl)ethenone sau 1-pentyl-3-(2-methylphenylacetyl)indole | 0,001 g | 0,001 g - 0,1 g |
| 458. | Methanandamide / C23H39NO2 / N-(1-hydroxypropan-2-yl)icosa-5,8,11,14-tetraenamide sau AM-356 | 0,001 g | 0,001 g - 0,1 g |
| 459. | JWH-182 / C27H29NO / 1-pentylindol-3-yl(4-propylnaphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 460. | CRA-13 / C26H24O2 / naphthalen-1-yl(4-pentoxynaphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 461. | 3-(4-hydroxymethylbenzoyl)-1-pentylindole / C21H23NO2 / 4-(hydroxymethyl)phenyl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 462. | JWH-203 / C21H22CINO / 2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethenone | 0,001 g | 0,001 g - 0,1 g |
| 463. | JWH-019 / C25H25NO / 1-hexyl-1H-indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 464. | JWH-015 / C23H21NO / 2-methyl-1-propyl-1H-indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 465. | JWH-081 / C25H25NO2 / 4-methoxynaphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 466. | RCS-4 / C21H23NO2 / 4-methoxyphenyl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 467. | JWH-200 / C25H24N2O2 / 1-(2-morpholin-4-ylethyl)indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 468. | 4-Cl-alpha-PVP / C15H20ClNO / 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one sau 4-chloro-α-pyrrolidinovalerophenone, 4-chloro-alpha-pyrrolidinopentiophenone | 0,001 g | 0,001 g - 0,1 g |
| 469. | 4-F-alpha-PHP / C16H22FNO / 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one sau 4'-fluoro-α-Pyrrolidinohexanophenone, 4-fluoro-PHP | 0,001 g | 0,001 g - 0,1 g |
| 470. | bk-IBP / bk-EABDI / C15H21NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)butan-1-one sau NEB-Inden-Analog | 0,001 g | 0,001 g - 0,1 g |
| 471. | 2-MEC / C12H17NO / 2-(ethylamino)-1-(o-tolyl)propan-1-one sau 2-Methylethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 472. | 5-PPDi / C17H23NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 473. | Propylcathinone / N-Propylcathinone / C12H17NO / 1-phenyl-2-(propylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 474. | 2,4-DMMC / C12H17NO / 1-(2,4-dimethylphenyl)-2-(methylamino)propan-1-one sau 2,4-Dimethylmethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 475. | 3,4-DMMC / C12H17NO / 1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one sau 3,4-Dimethylmethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 476. | 2,4-DMEC / C13H19NO / 1-(2,4-dimethylphenyl)-2-(ethylamino)propan-1-one sau 2,4-Dimethylethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 477. | 4-chloro-N,N-dimethylcathinone / 4-CDC / C10H12ClNO / 1-(4-chlorophenyl)-2-(dimethylamino)propan-1-one sau 4-Chloromethcathinone, Clephedrone, 4-CDMD | 0,001 g | 0,001 g - 0,1 g |
| 478. | N,N-Dimethylcathinone / C11H15NO / 2-(Dimethylamino)-1-phenylpropan-1-one sau Metamfepramone, Dimethylcathinone | 0,001 g | 0,001 g - 0,1 g |
| 479. | Nor-mephedrone / 4-Mc / C10H13NO / 2-amino-1-(p-tolyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 480. | 4-ethylethcathinone / 4-EEC / C13H19NO / 2-(ethylamino)-1-(4-ethylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 481. | 4-MeO-alpha-PV9 / C19H29NO2 / 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)octan-1-one sau 4-methoxy α-POP, para-methoxy PV9 | 0,001 g | 0,001 g - 0,1 g |
| 482. | 3,4-DMeO-alpha-PHP / 3,4-dimethoxy-alpha-PHP/ C18H27NO3 / 1-(3,4-dimethoxyphenyl)-2-(pyrrolidin-1-yl)hexan-1-one sau 2,4-DMeO-PHP | 0,001 g | 0,001 g - 0,1 g |
| 483. | 5-BPDi / C19H27NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 484. | alpha-pyrrolidinononaphenone / alpha-PNP / C19H29NO / 1-phenyl-2-pyrrolidin-1-ylnonan-1-one sau Nonanophenone | 0,001 g | 0,001 g - 0,1 g |
| 485. | 4Br-alpha-PVP / C15H20BrNO / 1-(4-Bromophenyl)-2-(1-pyrrolidinyl)-1-pentanone sau 4'-Bromo-α-Pyrrolidinopentiophenone, 4-bromo-α-pyrrolidinvalerophenone | 0,001 g | 0,001 g - 0,1 g |
| 486. | 4-fluoroethcathinone (4-FEC) / C11H14FNO / 2-(ethylamine)-1-(4-fluorphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 487. | 1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidinyl-1-yl) ethan-1-one / C21H23NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidinyl-1-yl)ethan-1-one sau Indapyrophenidone | 0,001 g | 0,001 g - 0,1 g |
| 488. | 5-DBFPV / C17H23NO2 / 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one sau 5-dihydrobenzofuranpyrovalerone | 0,001 g | 0,001 g - 0,1 g |
| 489. | 4F-PBP / C14H18FNO / 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-butanone | 0,001 g | 0,001 g - 0,1 g |
| 490. | bk-IVP / C16H23NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 491. | N-methyl-bk-MMDA-2 / C12H15NO4 / 1-(6-methoxy-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 492. | MMDA 2-methoxy analog / C11H15NO3 / 6-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine | 0,001 g | 0,001 g - 0,1 g |
| 493. | Methyl-MMDA-2 / C12H17NO3 / 1-(6-Methoxy-2H-1,3-benzodioxol-5-yl)-N-methylpropan-2-amine sau 6-methoxy-MDMA, 2-Methoxy-N-methyl-4,5-methylenedioxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 494. | MDPHP / 3,4-MDPHP / C17H23NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 495. | 4-MeO-alpha-PEP / 4-MeO-alpha-PV8 / C18H27NO2 / 1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)heptan-1-one sau 4-MeO-α-PHPP | 0,001 g | 0,001 g - 0,1 g |
| 496. | 4F-alpha-POP / 4F-PV9 / C18H26FNO / 1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)heptan-1-one sau 4-Fluoro-PV-9, FPOP, 4-Fluoro-α-POP | 0,001 g | 0,001 g - 0,1 g |
| 497. | 3-CMC / C10H12ClNO / 1-(3-chlorophenyl)-2-(methylamino)propan-1-one sau 3-chloromethcathinone, Clophedrone | 0,001 g | 0,001 g - 0,1 g |
| 498. | 4-methyl-N,N-diethylcathinone / 4-MDEC / C14H21NO / 2-(diethylamino)-1-(4-methylphenyl)propan-1-one sau N,N-DEMC, 4-MEC ET | 0,001 g | 0,001 g - 0,1 g |
| 499. | 4-MeO-alpha-PBP / 4-MeOPBP / C15H21NO2 / 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)butan-1-one sau 4-methoxy-α-Pyrrolidinobutiophenone | 0,001 g | 0,001 g - 0,1 g |
| 500. | alpha-PBT / C12H17NOS / 2-(Pyrrolidin-1-yl)-1-(thiophen-2-yl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 501. | 4F-alpha-PEP / 4F-PV8 / C17H24FNO / 1-(4-Fluorophenyl)-2-(pyrrolidin-1-yl)heptan-1-one sau 4F-α-PHPP | 0,001 g | 0,001 g - 0,1 g |
| 502. | 4-Methyl-N,N-dimethylcathinone / C12H17NO / 2-(dimethylamino)-1-(4-methylphenyl)-1-propanonem sau 4-methyl-N,N-DMC | 0,001 g | 0,001 g - 0,1 g |
| 503. | 4-methoxy-N,N-Dimethylcathinone / C12H17NO2 / 2-(dimethylamino)-1-(4-methoxyphenyl)-1-propanone sau N-Methylmethedrone | 0,001 g | 0,001 g - 0,1 g |
| 504. | 3-MEC sau 2-(Ethylamino)-1-(3-methylphenyl)propan-1-one sau 3-Methylethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 505. | 4-methylpentedrone / 4-MPD / C13H19NO / 2-(methylamino)-1-(4-methylphenyl)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 506. | Dipentylone / C14H19NO3 / 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 507. | 4-Fluoropentedrone / 4-FPD / C12H16FNO / 1-(4-fluorophenyl)-2-(methylamino)pentan-1-one sau 4-fluoro-α-methylamino-Valerophenone | 0,001 g | 0,001 g - 0,1 g |
| 508. | 2-methylmethcathinone (2-MMC) / C11H16ClNO / 2-(methylamino)-1-(2-methylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 509. | DL-4662 / C15H23NO3 / -(3,4-Dimethoxyphenyl)-2-(ethylamino)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 510. | 1-(4-fluorophenyl)-2-(piperidin-1-yl)pentan-1-one sau 1-(4-fluorophenyl)-2-(piperidin-1-yl)pentan-1-one sau 4-Fluoro-α-PVP piperidine analog | 0,001 g | 0,001 g - 0,1 g |
| 511. | 4-Fluoro-α-PVP / C15H20FNO / 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one sau 4F-PVP, 4-fluoro-α-pyrrolidinovalerophenone | 0,001 g | 0,001 g - 0,1 g |
| 512. | N-ethylnorpentedrone / C13H19NO / 1-phenyl-2-(ethylamino)pentan-1-one sau α-ethylaminopentiophenone, N-Ethylpentylone, NEP | 0,001 g | 0,001 g - 0,1 g |
| 513. | Hexedrone / ß-propylmethcathinone / C13H19NO / 2-(Methylamino)-1-phenylhexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 514. | Butylhexedrone / C16H25NO / 2-(butylamino)-1-phenylhexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 515. | 4'-chloro-alpha-PPP / C13H16ClNO / 1-(4-chlorophenyl)-2-pyrrolidin-1-ylpropan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 516. | 4-fluoro-N-isopropylnorpentedrone / 4F-IPV / C14H20FNO / 1-(4-Fluorophenyl)-2-(isopropylamino)pentan-1-one sau 4-Fluoro-N-isopropylpentedrone | 0,001 g | 0,001 g - 0,1 g |
| 517. | 3-methoxymethcathinone / 3-MeOMC / C11H15NO2 / 1-(3-methoxyphenyl)-2-(methylamino)propan-1-one sau 3-MOMC | 0,001 g | 0,001 g - 0,1 g |
| 518. | 4F-alpha-PVP / C15H20FNO / 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-pentanone sau 4F-α-PVP | 0,001 g | 0,001 g - 0,1 g |
| 519. | 3,4-DMeO-alpha-PVP / C17H25NO3 / 1-(3,4-Dimethoxyphenyl)-2-(1-pyrrolidinyl)-1-pentanone sau 3',4'-Dimethoxy-α-Pyrrolidinopentiophenone | 0,001 g | 0,001 g - 0,1 g |
| 520. | 4-BEC / C11H14BrNO / 1-(4-Bromophenyl)-2-(ethylamino)-1-propanone | 0,001 g | 0,001 g - 0,1 g |
| 521. | 3,4-Dimethylethcathinone (3,4-DMEC) / C13H19NO / 1-(3,4-Dimethylphenyl)-2-(ethylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 522. | 4-Methyl-N-ethylnorpentedrone / C14H21NO / 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one sau 4-MEAP | 0,001 g | 0,001 g - 0,1 g |
| 523. | bk-2C-B / C10H12BrNO3 / 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 524. | 2-FMC / 2-Fluoromethcathinone / C10H12FNO / 1-(2-fluorophenyl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 525. | bk-PBDB / C14H19NO3 / 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 526. | 4-methylbuphedrone, N-benzyl derivative / C18H21NO / 2-(benzylamino)-1-(4-methylphenyl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 527. | 4-MeO-alpha-PVP / C16H23NO2 / 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)pentan-1-one sau 4-Methoxy-a-PVP, 4-Methoxy-a-Pyrrolidinopentiophenone | 0,001 g | 0,001 g - 0,1 g |
| 528. | 4-Fluorocathinone / C9H10FNO / 2-amino-1-(4-fluorophenyl)propan-1-one sau 4-FC | 0,001 g | 0,001 g - 0,1 g |
| 529. | 2,4,5-Trimethylmethcathinone / 2,4,5-TMMC / C13H19NO / 2-(methylamino)-1-(2,4,5-trimethylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 530. | 1-phenyl-2-(piperidin-1-yl)butan-1-one / C15H21NO / 1-phenyl-2-(piperidin-1-yl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 531. | alpha-Pyrrolidinobutyrophenone / alpha-PBP / C14H19NO / 1-Phenyl-2-(1-pyrrolidinyl)-1-butanone | 0,001 g | 0,001 g - 0,1 g |
| 532. | 4-Methylbuphedrone / 4-Me-MABP / C12H17NO / 2-(methylamino)-1-(4-methylphenyl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 533. | Dimethylone / bk-MDDMA / C12H15NO3 / 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 534. | Brephedrone / 4-BMC /C10H12BrNO / 1-(4-bromophenyl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 535. | 4-Ethylmethcathinone / 4-EMC / C12H17NO / 1-(4-ethylphenyl)-2-(methylamino)propan-1-one sau 4-Ethylphedrone | 0,001 g | 0,001 g - 0,1 g |
| 536. | N-ethylbuphedrone / C12H17NO / 2-(ethylamino)-1-phenylbutan-1-one sau NEB | 0,001 g | 0,001 g - 0,1 g |
| 537. | 2-Benzylamino-1-(3,4-methylenedioxyphenyl)propan-1-one / BMDP / C17H17NO3 / 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 538. | 2-Benzylamino-1-(3,4-methylenedioxyphenyl)butan-1-one / BMDB / C18H19NO3 / 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 539. | 3,4-dimethylmethcathinone / 3,4-DMMC / C12H17NO / 1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 540. | Benzedrone / 4-MBC / C17H19NO / 2-(benzylamino)-1-(4-methylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 541. | 1-naphyrone / C19H23NO / 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one sau α-Naphyrone | 0,001 g | 0,001 g - 0,1 g |
| 542. | Pentylone / C13H17NO3 / 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one sau bk-MDBP | 0,001 g | 0,001 g - 0,1 g |
| 543. | Pentedrone / ß-ethyl-methcathinone / C12H17NO / 1-(methylamino)-1-phenylpentan-2-one, 1-phenyl-2-(methylamino)pentan-1-one sau α-methylamino-valerophenone | 0,001 g | 0,001 g - 0,1 g |
| 544. | 3',4'- Methylenedioxy-alpha-methylPPP /MDMPP / C15H19NO3/ 1-(2H-1,3-Benzodioxol-5-yl)-2-methyl-2-(pyrrolidin-1-yl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 545. | Buphedrone / C11H15NO / 2-(methylamino)-1-phenylbutan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 546. | 4-Fluorobuphedrone/ C11H14FNO / 1-(4-fluorophenyl)-2-(methylamino)butan-1-one sau 4-FBP, 4-F-MABP | 0,001 g | 0,001 g - 0,1 g |
| 547. | 4Cl-Buphedrone / C11H14ClNO / 1-(4-chlorophenyl)-2-(methylamino)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 548. | 4'-Methyl-alpha-pyrrolidinobutyrophenone / MPBP / C15H21NO / 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)butan-1-one sau F 1938 | 0,001 g | 0,001 g - 0,1 g |
| 549. | 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone / MDPBP / C15H19NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 550. | Naphyrone / C19H23NO / (RS)-1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one sau Naphthylpyrovalerone | 0,001 g | 0,001 g - 0,1 g |
| 551. | Metamfepramone / C11H15NO / 2-dimethylamino-1-phenylpropan-1-one sau 2-(dimethylamino)propiophenone, N,N-Dimethylcathinone, Dimethylpropione, Dimepropione | 0,001 g | 0,001 g - 0,1 g |
| 552. | Methedrone / bk-PMMA / C11H15NO2 / 1-(4-methoxyphenyl)-2-(methylamino)propan-1-one sau para-Methoxymethcathinone, PMMC, Methoxyphedrine, 4-Methedrone | 0,001 g | 0,001 g - 0,1 g |
| 553. | alpha-Pyrrolidinopropiophenone / alpha-PPP / C13H17NO / 1-phenyl-2-(pyrrolidin-1-yl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 554. | alpha-PPP-MeO / C14H19NO2 / 3-methoxy-1-phenyl-2-(pyrrolidin-1-yl)propan-1-one sau PMeOPP | 0,001 g | 0,001 g - 0,1 g |
| 555. | 3-fluoromethcathinone / 3-FMC / C10H12FNO / 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one sau Fluphedrone | 0,001 g | 0,001 g - 0,1 g |
| 556. | Ethylcathinone / Ethcathinone / C11H15NO / 2-(ethylamino)-1-phenyl-1-propanone sau N-Ethylcathinone | 0,001 g | 0,001 g - 0,1 g |
| 557. | 3',4'-Methylenedioxy-alpha-PPP / MDPPP / C14H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 558. | 4'-Methoxy-alpha-PPP / MOPPP / C14H19NO2 / 1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)propan-1-one sau MeOPPP, pMPPP, 4′-Methoxy-α-pyrrolidinopropiophenone | 0,001 g | 0,001 g - 0,1 g |
| 559. | 4'-Methyl-alpha-pyrrolidinohexanophenone / MPHP / C17H25NO / 1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one sau 4′-Methyl-α-pyrrolidinohexanophenone | 0,001 g | 0,001 g - 0,1 g |
| 560. | MPHP-2201 / C24H27FN2O3 / methyl (1-(5-fluoropentyl)-1H-indole-3-carbonyl)phenylalaninate, methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3-phenylpropanoate sau 5F-MPP-PICA, 5F-MPhP-PICA | 0,001 g | 0,001 g - 0,1 g |
| 561. | Ethylone / bk-MDEA / C12H15NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one sau EtONE, Ethylone, 3,4-Methylenedioxyethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 562. | McPT / MCPT / C14H18N2 / N-[2-(1H-Indol-3-yl)ethyl]-N-methylcyclopropanamine | 0,001 g | 0,001 g - 0,1 g |
| 563. | AL-LAD / C22H27N3O / N,N-Diethyl-6-(prop-2-en-1-yl)-9,10-didehydroergoline-8β-carboxamide; (6aR,9R)-N,N-Diethyl-7-(prop-2-en-1-yl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamid sau AL-LAD; ALLAD; 6-Allyl-N,N-diethyl-6-norlysergamide; N-Allyl-nor-LSD; N-(6)-Allylnorlysergic acid, N,N-diethylamide; 9,10-Didehydro-6-allyl-N,N-diethylergoline-8β-carboxamide; N,N-Diethylnorlysergamide, 6-allyl; 6-Norlysergamide, 6-allyl-N,N-diethyl | 0,001 g | 0,001 g - 0,1 g |
| 564. | 5-MeO-EIPT / C16H24N2O / N-Ethyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine sau 5-Methoxy-N-ethyl-N-isopropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 565. | 5-MeO-NiPT/ 5-MeO-NIPT / C14H20N2O / N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]propan-2-amine sau N-Isopropyl-5-methoxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 566. | 5-MeO-MALT / C15H20N2O / N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 567. | 2-Me-DMT / C13H18N2 / N,N-Dimethyl-2-(2-methyl-1H-indol-3-yl)ethan-1-amine sau Desmethoxy-Indapex; 3-[2-(Dimethylamino)ethyl]-2-methylindole; Indole, 3-[2-(dimethylamino)ethyl]-2-methyl; 2,N,N-TMT; 2,N,N-Trimethyltryptamine; Tryptamine, 2,N,N-trimethyl | 0,001 g | 0,001 g - 0,1 g |
| 568. | 4-AcO-DPT/ C18H26N2O2 / 3-[2-(Dipropylamino)ethyl]-1H-indol-4-yl acetate sau 4-Acetoxy-N,N-dipropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 569. | 4-HO-DPT / C16H24N2O / 3-(2-(dipropylamino)ethyl)-1H-indol-4-ol sau 4-Hydroxy-dipropyltryptamine; N,N-Dipropyl-4-hydroxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 570. | 5-MeO-MET / C14H20N2O / N-Ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 571. | 6-MeO-DIPT / C17H26N2O / N-isopropyl-N-(2-(6-methoxy-1H-indol-3-yl)ethyl)propan-2-amine sau 6-Methoxy-N,N-diisopropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 572. | 4-AcO-DALT / C18H22N2O2 / -{2-[Di(prop-2-en-1-yl)amino]ethyl}-1H-indol-4-yl acetate sau 4-Acetoxy-N,N-diallyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 573. | 5-MeO-DPT / C17H26N2O / N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine sau 5-Methoxy-N,N-dipropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 574. | 4-AcO-MET / Metacetin / C15H20N2O2 / 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-yl acetate sau 4-Acetoxy-N-ethyl-N-methyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 575. | 5-HO-DMT / Bufotenine / C12H16N2O / 3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol sau Mappine Tryptamine, N,N-dimethyl-5-hydroxy | 0,001 g | 0,001 g - 0,1 g |
| 576. | 4-HO-MIPT / Miprocin / C14H20N2O / -{2-[Methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol sau 4-Hydroxy-N-isopropyl-N-methyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 577. | 5-MeO-DET / C15H22N2O / N,N-Diethyl-2-(5-methoxy-1H-indol-3-yl)ethan-1-amine sau N,N-Diethyl-5-methoxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 578. | 4-AcO-DET / C16H22N2O2 / 3-[2-(Diethylamino)ethyl]-1H-indol-4-yl acetate sau Ethacetin, Ethylacybin | 0,001 g | 0,001 g - 0,1 g |
| 579. | DPT / C16H24N2 / N-[2-(1H-Indol-3-yl)ethyl]-N-propylpropan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 580. | 4-AcO-DPT / C18H26N2O2 / 3-(2-(dipropylamino)ethyl)-1H-indol-4-yl acetate sau 4-Acetoxy-N,N-dipropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 581. | 5-EtO-DPT / C18H28N2O / N-[2-(5-Ethoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 582. | 4-AcO-MIPT / Mipracetin / C16H22N2O2 / 3-{2-[Methyl(propan-2-yl)amino]ethyl}-1H-indol-4-yl acetat | 0,001 g | 0,001 g - 0,1 g |
| 583. | 5-MeO-DIPT / C17H26N2O / N-[2-(5-Methoxy-1H-indol-3-yl) ethyl]-N-(propan-2-yl) propan-2-amine sau N ,N-Diisopropyl-5-methoxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 584. | 4-AcO-DIPT sau 3-(2-(diisopropylamino) ethyl)-1H-indol-4-yl acetate sau Ipracetin, 4-Acetoxy-DIPT | 0,001 g | 0,001 g - 0,1 g |
| 585. | MIPT / C14H20N2 / N-[2-(1H-Indol-3-yl)ethyl]-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 586. | 4-HO-DIPT / C16H24N2O / 3-{2-[Di(propan-2-yl)amino]ethyl}-1H-indol-4-ol; 3-(2-(diisopropylamino)ethyl)-1H-indol-4-ol sau Iprocin | 0,001 g | 0,001 g - 0,1 g |
| 587. | 5,6-MDO-MIPT / C15H20N2O2 / N-[2-(5H-[1,3]Dioxolo[4,5-f]indol-7-yl)ethyl]-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 588. | 5-Me-MIPT / C15H22N2 / N-Methyl-N-[2-(5-methyl-1H-indol-3-yl)ethyl]propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 589. | 4-HO-DET / C14H20N2O / -[2-(Diethylamino)ethyl]-1H-indol-4-o sau Ethocin, CZ-74 | 0,001 g | 0,001 g - 0,1 g |
| 590. | DIPT / C16H24N2 / N-[2-(1H-Indol-3-yl)ethyl]-N-(propan-2-yl)propan-2-amine sau N,N-Diisopropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 591. | 5-MeO-AMT / C12H16N2O / 1-(5-Methoxy-1H-indol-3-yl)propan-2-amine sau Alpha-O; α,O-Dimethylserotonin | 0,001 g | 0,001 g - 0,1 g |
| 592. | 4-methoxybutyrfentanyl / 4-MeO-BF / C24H32N2O2 / N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide | 0,001 g | 0,001 g - 0,1 g |
| 593. | Despropionyl-2-fluoro fentanyl / C19H23FN2 / N-(2-fluorophenyl)-1-(2-phenylethyl) piperidin-4-amine | 0,001 g | 0,001 g - 0,1 g |
| 594. | U-47700 / C16H22Cl2N2O / 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide | 0,001 g | 0,001 g - 0,1 g |
| 595. | Methene-U-47700 / C17H24Cl2N2O / 2-(3,4-dichlorophenyl)-N-(2-(dimethylamino)cyclohexyl)-N-methylacetamide sau U-51754 | 0,001 g | 0,001 g - 0,1 g |
| 596. | Isopropyl-U-47700 / C18H26Cl2N2O / 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-(propan-2-yl)benzamide | 0,001 g | 0,001 g - 0,1 g |
| 597. | N-desmethyl-U-47700 / C15H20Cl2N2O / 3,4-dichloro-N-methyl-N-[(1R,2R)-2-(methylamino)cyclohexyl]benzamide | 0,001 g | 0,001 g - 0,1 g |
| 598. | W-18 / C19H20ClN3O4S / 4-Chloro-N-{1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene}benzene-1-sulfonamide | 0,001 g | 0,001 g - 0,1 g |
| 599. | Acetylfentanyl / C21H26N2O / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | 0,001 g | 0,001 g - 0,1 g |
| 600. | Cyclopropylacetylfentanyl / C24H30N2O / 2-Cyclopropyl-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | 0,001 g | 0,001 g - 0,1 g |
| 601. | Ethoxyacetylfentanyl / C23H30N2O2 / 2-Ethoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | 0,001 g | 0,001 g - 0,1 g |
| 602. | Methoxyacetylfentanyl / C22H28N2O2 / 2-Methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide sau Methoxyacetyl-F | 0,001 g | 0,001 g - 0,1 g |
| 603. | 4-fluoro-butyrfentanyl / 4F-BF / C23H29FN2O / 1-((4-fluorophenyl)(1-phenethylpiperidin-4-yl)amino)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 604. | 2-FIBF / C23H29FN2O / N-(2-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propenamide sau 2-Fluoroisobutyryl fentanyl | 0,001 g | 0,001 g - 0,1 g |
| 605. | 4F-IBF / C23H29FN2O / N-(4-Fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propenamide sau p-Fluoro-isobutyrylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 606. | MT-45 / C24H32N2 / 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine | 0,001 g | 0,001 g - 0,1 g |
| 607. | 2F-MT-45 / C24H31FN2 / 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine sau 2-fluoro I-C6 | 0,001 g | 0,001 g - 0,1 g |
| 608. | 3F-MT-45 / C24H31FN2 / 1-Cyclohexyl-4-[1-(3-fluorophenyl)-2-phenylethyl]piperazine | 0,001 g | 0,001 g - 0,1 g |
| 609. | W-15 / C19H21ClN2O2S / 4-Chloro-N-[1-(2-phenylethyl)piperidin-2-ylidene]benzene-1-sulfonamide | 0,001 g | 0,001 g - 0,1 g |
| 610. | (Iso)butyryl-F-fentanyl N-benzyl analogue / C22H27FN2O / 2-methyl-N-(1-benzylpiperidin-4-yl)-N-(4-fluorophenyl)propanamide | 0,001 g | 0,001 g - 0,1 g |
| 611. | Phenetrazine / C12H17NO / 3-ethyl-2-phenylmorpholine | 0,001 g | 0,001 g - 0,1 g |
| 612. | 3F-Phenetrazine / C12H16FNO / 3-ethyl-2-(3-fluorophenyl)morpholine | 0,001 g | 0,001 g - 0,1 g |
| 613. | 4-MPH sau 3-methyl-2(p-tolyl)morpholine sau Mephenmetrazine; 4-methylphenmetrazine | 0,001 g | 0,001 g - 0,1 g |
| 614. | 3,4-DMAR / C11H14N2O / 3,4-Dimethyl-5-phenyl-1,3-oxazolidin-2-imine sau 3,4-Dimethylaminorex | 0,001 g | 0,001 g - 0,1 g |
| 615. | N-methyl aminorex derivativ / C10H12N2O / 3-Methyl-5-phenyl-1,3-oxazolidin-2-imine sau 3-Methylaminorex; 3-MAR; 5-phenyl-2-amino-N-methyl-oxazoline | 0,001 g | 0,001 g - 0,1 g |
| 616. | 4-methylpentan-2-amine / DMBA / C6H15N / 4-methylpentan-2-amine sau 1,3-DMBA; 1,3-Dimethylbutylamine | 0,001 g | 0,001 g - 0,1 g |
| 617. | Modafinil sulphone / C15H15NO3S / 2-(Diphenylmethanesulfonyl)acetamide sau CRL-41056 | 0,001 g | 0,001 g - 0,1 g |
| 618. | Flmodafinil / C15H13F2NO2S / 2-[Bis(4-fluorophenyl)methanesulfinyl]acetamide sau CRL-40,940 | 0,001 g | 0,001 g - 0,1 g |
| 619. | Afloqualone / C16H14FN3O / 6-Amino-2-(fluoromethyl)-3-(2-methylphenyl)quinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 620. | Modafiendz / C16H15F2NO2S / 2-[Bis(4-fluorophenyl)methanesulfinyl]-N-methylacetamide sau N-Methylbisfluoromodafinil | 0,001 g | 0,001 g - 0,1 g |
| 621. | Methylmethaqualone / MMQ / C17H16N2O / 3-(2,4-Dimethylphenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 622. | NPDPA / C17H21N / N-(1,2-Diphenylethyl)propan-2-amine sau Isophenidine, Isopropylphenidine | 0,001 g | 0,001 g - 0,1 g |
| 623. | Mesembrine / C17H23NO3 / 3a-(3,4-Dimethoxyphenyl)-1-methyloctahydro-6H-indol-6-one | 0,001 g | 0,001 g - 0,1 g |
| 624. | Diphenidine / C19H23N / 1-(1,2-Diphenylethyl)piperidine sau 1,2-DEP; DPH; DPP | 0,001 g | 0,001 g - 0,1 g |
| 625. | 2-Chlorodiphenidine / C19H22ClN / 1-[1-(2-Chlorophenyl)-2-phenylethyl]piperidine sau 2-Cl-DPH; 2-Cl-DPP | 0,001 g | 0,001 g - 0,1 g |
| 626. | 3-Methoxydiphenidine / C20H25NO / 1-[1-(3-Methoxyphenyl)-2-phenylethyl]piperidine sau 3-MXP | 0,001 g | 0,001 g - 0,1 g |
| 627. | Embutramide / C17H27NO3 / N-[2-Ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxybutanamide | 0,001 g | 0,001 g - 0,1 g |
| 628. | Sibutramine / C17H26ClN / 1-[1-(4-Chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 629. | Nitracaine / C16H24N2O4 / 3-(Diethylamino)-2,2-dimethylpropyl 4-nitrobenzoate | 0,001 g | 0,001 g - 0,1 g |
| 630. | RH-34 / C18H19N3O3 /3-(2-{[(2-Methoxyphenyl)methyl]amino}ethyl)quinazoline-2,4(1H,3H)-dione | 0,001 g | 0,001 g - 0,1 g |
| 631. | Mebroqualone / C15H11BrN2O / 3-(2-bromophenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 632. | Mephtetramine / MTTA / C12H15NO / 2-[(Methylamino)methyl]-3,4-dihydronaphthalen-1(2H)-one | 0,001 g | 0,001 g - 0,1 g |
| 633. | NMP / C10H9NO2 / 2-(Methylamino)-1H-indene-1,3(2H)-dione sau N-Methylphthalimide | 0,001 g | 0,001 g - 0,1 g |
| 634. | para-Methyl-4-methylaminorex/4,4′-DMAR / C11H14N2O / 4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine | 0,001 g | 0,001 g - 0,1 g |
| 635. | 4-methylphendimetrazine / C13H19NO / 3,4-Dimethyl-2-(4-methylphenyl)morpholine | 0,001 g | 0,001 g - 0,1 g |
| 636. | 4-Fluoroephedrine / C10H14FNO / (1R,2S)-1-(4-Fluorophenyl)-2-(methylamino)propan-1-ol | 0,001 g | 0,001 g - 0,1 g |
| 637. | 1-cyclohexyl-x-methoxybenzene / C13H18O / 1-(x-methoxyphenyl)cyclohexanol | 0,001 g | 0,001 g - 0,1 g |
| 638. | 3-Fluoro-isomethcathinone / 3-FiMC / C10H12FNO / 1-(3-Fluorophenyl)-1-(methylamino)propan-2-one | 0,001 g | 0,001 g - 0,1 g |
| 639. | Camfetamine / C14H19N / N-methyl-3-phenyl-norbornan-2-amine sau CFA | 0,001 g | 0,001 g - 0,1 g |
| 640. | 5-HTP / C12H17NO / (2S)-2-Amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid sau 5-Hydroxytryptophan; α-Carboxy-5-hydroxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 641. | Iso-ethcathinone / C11H15NO / 1-(Ethylamino)-1-phenylpropan-2-one | 0,001 g | 0,001 g - 0,1 g |
| 642. | DMAA / C10H13NO / 2-(Dimethylamino)-1-phenylethan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 643. | Etaqualone / C17H16N2O / 3-(2-Ethylphenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 644. | Etaqualone 3-ethylphenyl analog / C17H16N2O / 3-(3-ethylphenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 645. | pFBT / C15H18FNO2 / 8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 4-fluorobenzoate sau Fluorotropacocaine | 0,001 g | 0,001 g - 0,1 g |
| 646. | DXM / C18H25NO / 3-Methoxy-17-methyl-9α,13α,14α-morphinan sau Dextromethorphan | 0,001 g | 0,001 g - 0,1 g |
| 647. | 25C-NBF sau 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethan-1-amine sau 2C-C-NBF | 0,001 g | 0,001 g - 0,1 g |
| 648. | DOPR / C14H23NO2 / 1-(2,5-Dimethoxy-4-propylphenyl)propan-2-amine sau 4-Propyl-2,5-dimethoxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 649. | 4,3,5-DOPR / C14H23NO2 / 1-(3,5-Dimethoxy-4-propylphenyl)propan-2-amine sau 2,5-Dimethoxy-4-propylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 650. | DOF / C11H16FNO2 / 1-(4-fluoro-2,5-dimethoxyphenyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 651. | 4-CMA / C10H14ClN / 4-chloro-N,α-dimethyl-benzeneethanamine sau 4-Chloromethamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 652. | DOIP / C14H23NO2 / 1-[2,5-dimethoxy-4-(propan-2-yl)phenyl]propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 653. | 2C-TFM / C11H14F3NO2 / 2,5-dimethoxy-4-(trifluoromethyl)-benzeneethanamine sau 2C-CF3 | 0,001 g | 0,001 g - 0,1 g |
| 654. | 25I-NBF / C17H19FINO2 / N-(2-fluorobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine sau 25I-NB2F; 2C-I-NBF | 0,001 g | 0,001 g - 0,1 g |
| 655. | 25I-NB34MD / C18H20INO4 / N-(1,3-Benzodioxol-5-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 656. | 2-Chloro-4,5-MDMA / C11H14ClNO2 / 1-(6-Chloro-2H-1,3-benzodioxol-5-yl)-N-methylpropan-2-amine sau 6-Chloro-MDMA | 0,001 g | 0,001 g - 0,1 g |
| 657. | MMA / meta-Methoxyamphetamine / C10H15NO / 1-(3-methoxyphenyl)propan-2-amine sau 3-methoxyamphetamine; 3-MA | 0,001 g | 0,001 g - 0,1 g |
| 658. | 3-Methoxy-4-methylamphetamine / C11H17NO / 1-(3-Methoxy-4-methylphenyl)propan-2-amine sau 3,4-MMA; 3-Methoxy-4-methylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 659. | 4-EA NBOMe / C19H25NO / 1-(4-Ethylphenyl)-N-[(2-methoxyphenyl)methyl]propan-2-amine sau 4-Ethyl-N-(o-methoxybenzyl)amphetamine | 0,001 g | 0,001 g - 0,1 g |
| 660. | 3,4-DMA NBOMe / C19H25NO3 / 1-(3,4-Dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 661. | EFLEA / C12H17NO3 / 1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-N-hydroxy-N-methylpropan-2-amine sau N-Hydroxy-N-methyl-3,4-ethylenedioxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 662. | bk-3,4-MDPA / Propylone / C13H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one sau 3,4-methylenedioxy-N-propylcathinone | 0,001 g | 0,001 g - 0,1 g |
| 663. | 4-bromoamphetamine (4-BA) / C9H12BrN / 1-(4-Bromophenyl)propan-2-amine sau PBA | 0,001 g | 0,001 g - 0,1 g |
| 664. | 2-methoxyamphetamine / C10H15NO / 1-(2-Methoxyphenyl)propan-2-amine sau 2-MA; 2-MeO-AMP; NDMP | 0,001 g | 0,001 g - 0,1 g |
| 665. | 6-Bromo-MDMA / C11H14BrNO2 / 1-(6-Bromo-2H-1,3-benzodioxol-5-yl)-N-methylpropan-2-amine sau 2-Br-4,5-MDMA; 6-Br-MDMA | 0,001 g | 0,001 g - 0,1 g |
| 666. | N-methyl-2C-B / C11H16BrNO2 / 4-Bromo-N-methyl-2,5-dimethoxyphenethylamine; 2-(4-bromo-2,5-dimethoxyphenyl)-N-methylethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 667. | Methallylescaline / C14H21NO3 / 2-{3,5-Dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethan-1-amine sau MAL | 0,001 g | 0,001 g - 0,1 g |
| 668. | 30C-NBOMe / C20H26ClNO5 / 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 669. | 3C-E / C13H21NO3 / 1-(4-Ethoxy-3,5-dimethoxyphenyl)propan-2-amine sau 4-Ethoxy-3,5-dimethoxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 670. | 3C-P / C14H23NO3 / 1-(3,5-Dimethoxy-4-propoxyphenyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 671. | 25I-NBMD / C18H20INO4 / N-(1,3-Benzodioxol-4-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine sau 2C-I-NBMD; Cimbi-29; 25I-DMBD | 0,001 g | 0,001 g - 0,1 g |
| 672. | Proscaline / C13H21NO3 / 2-(3,5-Dimethoxy-4-propoxyphenyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 673. | 2-(2,3-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethanamine / C20H27NO5 / 2-(2,3-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethanamine sau 2,3-DMPEA-NBTOMe | 0,001 g | 0,001 g - 0,1 g |
| 674. | AL – allylescaline / C13H19NO3 / 2-[3,5-Dimethoxy-4-(prop-2-en-1-yloxy) phenyl] ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 675. | Escaline / C12H19NO3 / 2-(4-Ethoxy-3,5-dimethoxyphenyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 676. | N-ethyl-1-phenylbutan-2-amine / C12H19N / N-ethyl-1-phenylbutan-2-amine sau N-ethyl-1-phenethyl-2-butylamine | 0,001 g | 0,001 g - 0,1 g |
| 677. | 25H-NBOMe / C18H23NO3 / 2-(2,5-Dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl] ethan-1-amine sau DMPEA-NBOMe; 2C-H-NBOMe | 0,001 g | 0,001 g - 0,1 g |
| 678. | 4-chloroamphetamine/4-CA / C9H12ClN / 1-(4-Chlorophenyl)propan-2-amine sau 4-Cl-AMP; PCA | 0,001 g | 0,001 g - 0,1 g |
| 679. | 4-Hydroxyamphetamine / C9H13NO / 4-(2-Aminopropyl)phenol sau 4-OH-A; PHA | 0,001 g | 0,001 g - 0,1 g |
| 680. | 2C-G / C12H19NO2 / 2-(2,5-Dimethoxy-3,4-dimethylphenyl)ethan-1-amine sau 2,5-Dimethoxy-3,4-dimethylphenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 681. | 2C-N / C10H14N2O4 / 2-(2,5-Dimethoxy-4-nitrophenyl)ethan-1-amine sau 2,5-Dimethoxy-4-nitrophenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 682. | 25E-NBOMe / C20H27NO3 / 2-(4-Ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethan-1-amine sau 25E-NBOMe | 0,001 g | 0,001 g - 0,1 g |
| 683. | 25G-NBOMe / C20H27NO3 / 2-(2,5-Dimethoxy-3,4-dimethylphenyl)-N-(2-methoxybenzyl) ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 684. | 25N-NBOMe / C18H22N2O5 / 2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethan-1-amine sau 2C-N-NBOMe | 0,001 g | 0,001 g - 0,1 g |
| 685. | MDDM / C12H17NO2 / 1-(1,3-Benzodioxol-5-yl)-N,N-dimethylpropan-2-amine sau N,N-Dimethyl-MDA | 0,001 g | 0,001 g - 0,1 g |
| 686. | 2-FMA / C10H14FN / 1-(2-Fluorophenyl)-N-methylpropan-2-amine sau 2-Fluoromethamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 687. | N-Propylamphetamine/PA / C12H19N / 1-phenyl-N-propylpropan-2-amine sau d-N-Propylamphetamine; Propylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 688. | DMMA / C12H19NO2 / 1-(3,4-Dimethoxyphenyl)-N-methylpropan-2-amine sau Dimethoxymethamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 689. | Dimethylamphetamine / C11H17N / N,N-Dimethyl-1-phenylpropan-2-amine sau Metrotonin; DIMETH; N,N-Dimethylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 690. | ß-Me-PEA / C9H13N / 2-Phenylpropylamine sau 2-Phenylpropylamine; beta-Methylphenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 691. | N,N-dimethylphenethylamine / C10H15N / N,N-Dimethyl-2-phenylethan-1-amine sau N,N-DMPEA; N,N-MePEA | 0,001 g | 0,001 g - 0,1 g |
| 692. | 4-FMA sau 4-Fluoromethamphetamine; 4F-MA | 0,001 g | 0,001 g - 0,1 g |
| 693. | 3-FMA / C10H14FN / 1-(3-Fluorophenyl)-N-methylpropan-2-amine sau 3-Fluoromethamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 694. | TMA-6 / C12H19NO3 / 1-(2,4,6-Trimethoxyphenyl)propan-2-amine sau 2,4,6-Trimethoxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 695. | 3- fluoroamphetamine /3-FA / C9H12FN / 1-(3-Fluorophenyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 696. | 4-Fluoroamphetamine/4-FA / C9H12FN / 1-(4-Fluorophenyl)propan-2-amine sau 4-FA; 4F-AMP | 0,001 g | 0,001 g - 0,1 g |
| 697. | N-Acetyl-DOB / C13H18BrNO3 / N-[1-(4-Bromo-2,5-dimethoxyphenyl)propan-2-yl]acetamide sau DOB-Ac | 0,001 g | 0,001 g - 0,1 g |
| 698. | PMEA / C12H19NO / N-Ethyl-1-(4-methoxyphenyl)propan-2-amine sau N-Et-PMA; p-Methoxyethylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 699. | NMPEA / C9H13N / N-Methyl-2-phenylethan-1-amine sau N-Methylphenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 700. | 2,4-DMA / C12H19NO / N-Ethyl-1-(4-methoxyphenyl)propan-2-amine sau N-Et-PMA; PMEA | 0,001 g | 0,001 g - 0,1 g |
| 701. | 2C-E / C12H19NO2 / 2-(4-Ethyl-2,5-dimethoxyphenyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 702. | 2C-D / C11H17NO2 / 2,5-Dimethoxy-4-methylphenethylamine; LE-25 | 0,001 g | 0,001 g - 0,1 g |
| 703. | 2C-P / C13H21NO2 / 2-(2,5-Dimethoxy-4-propylphenyl)ethan-1-amine sau Selene; 2,5-Dimethoxy-4-n-propylphenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 704. | Pyrrole, 1-tert-butyl-2, 4-diphenyl / C20H21N / Pyrrole, 1-tert-butyl-2, 4-diphenyl | 0,001 g | 0,001 g - 0,1 g |
| 705. | MDMB-4en-PINACA / C20H27N3O3 / Methyl (2S)-3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate sau MDMB(N)-022, ADB-PINACA-A | 0,001 g | 0,001 g - 0,1 g |
| 706. | 8-Amino–5–[S-hexylthio]–6–methoxy–2–methylquniloine / C17H24N2OS / 8-Amino–5–[S-hexylthio]–6–methoxy–2–methylquniloine | 0,001 g | 0,001 g - 0,1 g |
| 707. | MDPPP / 3′,4′–Methylenedioxy – α – pyrrolidinopropiophenone / C14H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 708. | P2NP / 1-Phenyl–2-nitropropene / C9H9NO2 / 2-nitroprop-1-en-1-yl benzene sau Methylnitrostyrene | 0,001 g | 0,001 g - 0,1 g |
| 709. | Eutylone / β – Keto-1,3 – benzodioxolyl – N – ethylbutanamine / C13H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one sau bk-EBDB | 0,001 g | 0,001 g - 0,1 g |
| 710. | 1–(4–Chlorophenyl)–2–(N-ethylamino)propan–1–one / C11H14C1NO / 1–(4–Chlorophenyl)–2–(N-ethylamino)propan–1–one sau 4-CEC; 4-Chloroethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 711. | α – Propylaminopentiophenone / C14H21NO / 1-Phenyl-2-[(propan-2-yl)amino]pentan-1-one sau N-PP; N-Propylpentedrone | 0,001 g | 0,001 g - 0,1 g |
| 712. | 2 – Pyrrolidino – 4bicyclo - methylacetophe | 0,001 g | 0,001 g - 0,1 g |
| 713. | 4′ – chloro – α – Pyrrolidinovalerophenone / C15H20C1NO / 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one sau 4-chloro-α-PVP, 4Cl-PVP, 4C-PVP | 0,001 g | 0,001 g - 0,1 g |
| 714. | Parafluorobutyrylfentanyl / C23H29FN2O / N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide sau 4-Fluorobutyrfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 715. | Ortho-fluorofentanyl / C22H27FN2O / N-(2-Fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide | 0,001 g | 0,001 g - 0,1 g |
| 716. | Methoxyacetyl fentanyl / C22H28N2O2 / 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide sau MAF | 0,001 g | 0,001 g - 0,1 g |
| 717. | Cyclopropylfentanyl / C23H28N2O / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide | 0,001 g | 0,001 g - 0,1 g |
| 718. | CUMYL-4CN-BINACA / C22H24N4O / 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide sau CUMYL-CYBINACA; SGT-78 | 0,001 g | 0,001 g - 0,1 g |
| 719. | N-Ethylnorpentylone (ephylone) / C14H19NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one sau MDEVP; bk-EBDP | 0,001 g | 0,001 g - 0,1 g |
| 720. | Paramethoxybutyrylfentanyl / C24H32N2O2 / N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide sau 4-Methoxybutyrylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 721. | MPA/methylthienylpropamine / C8H13NS / N-Methyl-1-(thiophen-2-yl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 722. | AMB-FUBINACA / C21H22FN3O3 / methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoate sau FUB-AMB | 0,001 g | 0,001 g - 0,1 g |
| 723. | Fentanyl butanamide analog / C23H30N2O / N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide sau Butyrfentanyl; Butyrylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 724. | Alpha-methylfentanyl butanamide analog / C24H32N2O / N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenyl-butanamide sau alpha-methylbutyryl fentanyl | 0,001 g | 0,001 g - 0,1 g |
| 725. | Orthofluorofentanyl / C22H27FN2O / N-(2-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | 0,001 g | 0,001 g - 0,1 g |
| 726. | m-Fluorofentanyl / C22H27FN2O / N-(3-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | 0,001 g | 0,001 g - 0,1 g |
| 727. | Benocyclidine / C19H25NS / 1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine sau BTCP, BCP | 0,001 g | 0,001 g - 0,1 g |
| 728. | Methoxyketamine / C14H19NO2 / 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexan-1-one sau 2-MDCK | 0,001 g | 0,001 g - 0,1 g |
| 729. | Furanylfentanyl / C24H26N2O2 / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide sau Fu-F | 0,001 g | 0,001 g - 0,1 g |
| 730. | Diclazepam / C16H12Cl2N2O / 7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 731. | Clonazolam / C17H12ClN5O2 / 6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine sau Clonitrazolam | 0,001 g | 0,001 g - 0,1 g |
| 732. | 550/ Pyrazolam / C16H12BrN5 / 8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | 0,001 g | 0,001 g - 0,1 g |
| 733. | Mimosa tenuiflora: | ||
| - uscată | 1 g | 1 g – 300 g | |
| - verde | 10 g | 10g – 500 g | |
| 734. | ATHPINACA / C24H31N3O2 / N-(Adamantan-1-yl)-1-[(oxan-4-yl)methyl]-1H-indazole-3-carboxamide sau Adamantyl-THPINACA | 0,001 g | 0,001 g - 0,1 g |
| 735. | HOT-7 / C13H21NO3S / 2-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-N-hydroxyethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 736. | SCH-5472 / C19H23NO / 2-(Diphenylmethyl)-1-methylpiperidin-3-ol | 0,001 g | 0,001 g - 0,1 g |
| 737. | PSB-SB-1202 / C23H26O4 / 5-Methoxy-3-[(2-methoxyphenyl)methyl]-7-pentyl-2H-1-benzopyran-2-one | 0,001 g | 0,001 g - 0,1 g |
| 738. | 3-CAF / C24H15FN2O2 / Naphthalen-2-yl 1-(2-fluorophenyl)-1H-indazole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 739. | URB-602 / C19H21NO2 / cyclohexyl [1,1'-biphenyl]-3-ylcarbamate | 0,001 g | 0,001 g - 0,1 g |
| 740. | PRE-084 / C19H27NO3 / 2-(Morpholin-4-yl)ethyl 1-phenylcyclohexane-1-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 741. | FLEA / C11H15NO3 / 1-(1,3-Benzodioxol-5-yl)-N-hydroxy-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 742. | Benzylfentanyl / C21H26N2O / N-(1-Benzylpiperidin-4-yl)-N-phenylpropanamide | 0,001 g | 0,001 g - 0,1 g |
| 743. | 5-APB-NBOMe / C19H21NO2 / 1-(1-Benzofuran-5-yl)-N-[(2-methoxyphenyl)methyl]propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 744. | CP 50,556-1 / C27H35NO4 / (6S,6aR,9R,10aR)-9-Hydroxy-6-methyl-3-{[(2R)-5-phenylpentan-2-yl]oxy}-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl acetate sau Levonantradol | 0,001 g | 0,001 g - 0,1 g |
| 745. | D2PM / C17H19NO / Diphenyl(pyrrolidin-2-yl)methanol sau Diphenylprolinol | 0,001 g | 0,001 g - 0,1 g |
| 746. | JB-336 / C20H23NO3 / 1-Methylpiperidin-3-yl hydroxy(diphenyl)acetate | 0,001 g | 0,001 g - 0,1 g |
| 747. | LTI-701 / C20H21FN2O / 1-(5-fluoropentyl)-N-phenyl-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 748. | Thenylfentanyl / C19H24N2OS / N-Phenyl-N-{1-[(thiophen-2-yl)methyl]piperidin-4-yl}propanamide | 0,001 g | 0,001 g - 0,1 g |
| 749. | JB-318 / C21H25NO3 / 1-Ethylpiperidin-3-yl hydroxy(diphenyl)acetate sau N-Ethyl-3-piperidyl benzilate | 0,001 g | 0,001 g - 0,1 g |
| 750. | Etaqualone / C17H16N2O / 3-(2-Ethylphenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 751. | Nitromethaqualone / C16H13N3O4 / 3-(2-Methoxy-4-nitrophenyl)-2-methylquinazolin-4(3H)-one sau 4-Nitromethaqualone | 0,001 g | 0,001 g - 0,1 g |
| 752. | Adrafinil / C15H15NO3S / 2-(Diphenylmethanesulfinyl)-N-hydroxyacetamide | 0,001 g | 0,001 g - 0,1 g |
| 753. | Aprobarbital / C10H14N2O3 / 5-(prop-2-en-1-yl)-5-(propan-2-yl)-1,3-diazinane-2,4,6-trione | 0,001 g | 0,001 g - 0,1 g |
| 754. | Brallobarbital / C10H11BrN2O3 / 5-(2-bromoprop-2-enyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trionequaz | 0,001 g | 0,001 g - 0,1 g |
| 755. | Heptabarbital / C13H18N2O3 / 5-(cyclohepten-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione | 0,001 g | 0,001 g - 0,1 g |
| 756. | Quazepam / C17H11ClF4N2S / 7-Chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-1,4-benzodiazepine-2-thione | 0,001 g | 0,001 g - 0,1 g |
| 757. | Cloniprazepam / C19H16ClN3O3 / 5-(2-Chlorophenyl)-1-(cyclopropylmethyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 758. | M-ALPHA / C11H15NO2 / 1-(1,3-Benzodioxol-5-yl)-N-methylpropan-1-amine sau α-Ethyl-N-methylpiperonylamine | 0,001 g | 0,001 g - 0,1 g |
| 759. | Fonazepam / C15H10FN3O3 / 5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one sau Norflunitrazepam | 0,001 g | 0,001 g - 0,1 g |
| 760. | Cinazepam / C19H14BrClN2O5 / 4-{[7-Bromo-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]oxy}-4-oxobutanoic acid | 0,001 g | 0,001 g - 0,1 g |
| 761. | U-51754 / C17H24Cl2N2O / 2-(3,4-dichlorophenyl)-N-(2-(dimethylamino)cyclohexyl)acetamide | 0,001 g | 0,001 g - 0,1 g |
| 762. | MTTA / C12H15NO / 2-[(Methylamino)methyl]-3,4-dihydronaphthalen-1(2H)-one sau Mephtetramine | 0,001 g | 0,001 g - 0,1 g |
| 763. | Isopentedrone / C12H17NO / 1-(Methylamino)-1-phenylpentan-2-one | 0,001 g | 0,001 g - 0,1 g |
| 764. | TCM / C11H17NS / N-Methyl-1-(thiophen-2-yl)cyclohexan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 765. | 3-F-iso-MC / C10H12FNO / 1-(3-Fluorophenyl)-1-(methylamino)propan-2-one | 0,001 g | 0,001 g - 0,1 g |
| 766. | 3-MeO-PCMMo / C18H27NO2 / 4-{[1-(3-Methoxyphenyl) cyclohexyl]methyl}morpholine | 0,001 g | 0,001 g - 0,1 g |
| 767. | MDA-19 / C21H23N3O2 / (1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide | 0,001 g | 0,001 g - 0,1 g |
| 768. | Ibogaine / C20H26N2O / 12-Methoxyibogamine; 7-Ethyl-2-methoxy-6,6a,7,8,9,10,12,13-octahydro-5H-6,9-methanopyrido[1′,2′:1,2]azepino[4,5-b]indole | 0,001 g | 0,001 g - 0,1 g |
| 769. | HU-331 / C21H28O3 / (1'R)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione | 0,001 g | 0,001 g - 0,1 g |
| 770. | JWH-133 / C22H32O / 3-(1,1-dimethylbutyl)-6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran | 0,001 g | 0,001 g - 0,1 g |
| 771. | HU-308 / C27H42O3 / {(4S)-4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methanol | 0,001 g | 0,001 g - 0,1 g |
| 772. | URB-597 / C20H22N2O3 / 3′-Carbamoyl[1,1′-biphenyl]-3-yl cyclohexylcarbamate | 0,001 g | 0,001 g - 0,1 g |
| 773. | Harmine / C13H12N2O / 7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole; 7-Methoxy-1-methyl-9H-β-carboline sau Banisterine; Telepathine | 0,001 g | 0,001 g - 0,1 g |
| 774. | Epirocaine / C14H21NO2 / 2-Methyl-2-(propylamino)propyl benzoate sau Oracaine; Meprylcaine | 0,001 g | 0,001 g - 0,1 g |
| 775. | Modafiendz / C16H15F2NO2S / 2-[Bis(4-fluorophenyl)methanesulfinyl]-N-methylacetamide sau Methylbisfluoromodafinil | 0,001 g | 0,001 g - 0,1 g |
| 776. | Benzoylbenzylfentanyl / C25H26N2O / N-(1-Benzylpiperidin-4-yl)-N-phenylbenzamide | 0,001 g | 0,001 g - 0,1 g |
| 777. | Furanylbenzylfentanyl / C23H24N2O2 / N-(1-Benzylpiperidin-4-yl)-N-phenylfuran-2-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 778. | Methyl 1-benzyl-1H-indazole-3-carboxylate / C16H14N2O2 / Methyl 1-benzylindazole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 779. | U-48800 / C17H24Cl2N2O / 2-(2,4-Dichlorophenyl)-N-(2-(dimethylamino)cyclohexyl)-N-methylacetamide | 0,001 g | 0,001 g - 0,1 g |
| 780. | Thiofentanyl / C20H26N2OS / N-Phenyl-N-{1-[2-(thiophen-2-yl)ethyl]piperidin-4-yl}propenamide sau R-31826 | 0,001 g | 0,001 g - 0,1 g |
| 781. | Brifentanil / C20H29FN6O3 / 1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-3-methylpiperidin-4-yl]-N-(2-fluorophenyl)-2-methoxyacetamide sau A-3331 | 0,001 g | 0,001 g - 0,1 g |
| 782. | Trefentanil / C25H31FN6O2 / N-{1-[2-(4-Ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-phenylpiperidin-4-yl-N-(2-fluorophenyl)propenamide sau A-3665 | 0,001 g | 0,001 g - 0,1 g |
| 783. | Benzoylfentanyl / C26H28N2O / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]benzamide sau Phenylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 784. | Benzodioxolefentanyl / C27H28N2O3 / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2H-1,3-benzodioxole-5-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 785. | 3-Furanylfentanyl / C24H26N2O2 / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 786. | Flualprazolam / C17H12ClFN4 | 0,001 g | 0,001 g - 0,1 g |
| 787. | Crotonylfentanyl / N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2-butenamide / C23H28N2O | 0,001 g | 0,001 g - 0,1 g |
| 788. | Valerylfentanyl / C24H32N2O / N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide | 0,001 g | 0,001 g - 0,1 g |
| 789. | Peganum harmala : | ||
| - uscată | 1 g | 1 g – 300 g | |
| - verde | 10 g | 10g – 500 g | |
| 790. | Banisteriopsis caapi: | ||
| - uscată | 1 g | 1 g – 300 g | |
| - verde | 10 g | 10g – 500 g | |
| 791. | Psychotria viridis: | ||
| - uscată | 1 g | 1 g – 300 g | |
| - verde | 10 g | 10g – 500 g | |
| 792. | Cannabis: | ||
| - răşină de cannabis | 0,05 g | 0,05 g – 10,0 g | |
| - ulei de cannabis sau de haşiş | 0,1 g | 0,1 g – 10,0 g | |
| marijuana: | |||
| - uscată | 2,0 g | 2,0 g - 500 g | |
| - verde | 14,0 g | 14,0 g - 1000 g | |
| - haşiş | 0,5 g | 0,5 g – 50,0 g | |
| 793. | Izumetadom (Isomethadone / 6-(dimethylamino)-5-methyl-4,4-diphenylhexan-3-one) | 0,001 g | 0,001 g - 0,1 g |
| 794. | Levomoramide / 3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-ylbutan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 795. | AB-CHMINACA sau AB-PINACA-CHM / N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 796. | Fenmetrazin (Phenmetrazine / 3-Methyl-2-phenylmorpholine) | 0,001 g | 0,001 g - 0,1 g |
| 797. | APAAN (alfa-fenylacetoacetonitril) | 0,001 g | 0,001 g - 0,1 g |
| 798. | Pentedrone HCL /C12H17NO·HCI/ | 0,001 g | 0,001 g - 0,1 g |
| 799. | Rhodium, bis(ethylene)-indenyl- (C12H15Rh) | 0,001 g | 0,001 g - 0,1 g |
| 800. | 4-Fluoroisobutyrfentanyl (4-FIBF, pFIBF) | 0,001 g | 0,001 g - 0,1 g |
| 801. | Isotonitazene | 0,001 g | 0,001 g - 0,1 g |
| 802. | Quinoline-4-ol C17H22N2O2 / 6-methoxy-2-methyl-3-(1-piperidylmethyl) | 0,001 g | 0,001 g - 0,1 g |
| 803. | 4-AP N-Phenyl-4-Piperidinamine | 0,001 g | 0,001 g - 0,1 g |
| 804. | Nor fentanyl (N-phenyl-N-(piperidin-4-yl) propenamide) | 0,001 g | 0,001 g - 0,1 g"; |
d) la compartimentul II "Substanţe psihotrope":
la poziţia 32 în coloana a 2-a, cuvântul "Fenmetrazin" se substituie cu textul "Fenmetrazin (Phenmetrazine / 3-Methyl-2-phenylmorpholine)";
se completează cu poziţiile 171-182 cu următorul cuprins:
| "171. | 25B-NBOMe
C18H22BrNO3, Sinonim : 2-(4-bromo – 2,5-dimetoxypenyl)-N-[(2-metoxypenyl)methyl]etanamine |
0,01 g | 0,01 - 0,25 g |
| 172. | Propofol / C12H18O / 2,6-bis(propan-2-yl)phenol sau 2,6-Diisopropylphenol | 0,001 g | 0,001 g - 0,1 g |
| 173. | Scopolamine / C17H21NO4 / 9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 3-hydroxy-2-phenylpropanoate sau Hyoscine | 0,001 g | 0,001 g - 0,1 g |
| 174. | Etizolam (forma de prezentare tabletata) / C17H15ClN4S / 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | 0,001 g | 0,001 g - 0,1 g |
| 175. | Meclonazepam / C16H12ClN3O3 / (S)-3-methylclonazepam | 0,001 g | 0,001 g - 0,1 g |
| 176. | Fenibut (Phenibut / C10H13NO2 / 4-amino-3-phenyl-butyric acid sau Phenylgamma; PHG) | 0,001 g | 0,001 g - 0,1 g |
| 177. | Tapentadol / C14H23NO / 3-[(2R,3R)-1-(Dimethylamino)-2-methylpentan-3-yl]phenol sau BN-200 | 0,001 g | 0,001 g - 0,1 g |
| 178. | Adrafinil (pulbere) / C15H15NO3S / 2-(Diphenylmethanesulfinyl)-N-hydroxyacetamide | 0,001 g | 0,001 g - 0,1 g |
| 179. | Metizolam (tablete) / C16H13ClN4S / 4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine sau Desmethyletizolam | 0,001 g | 0,001 g - 0,1 g |
| 180. | Benzydamine / C19H23N3O / 3-[(1-Benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 181. | Amyl-nitrite / C5H11NO2 / pentyl nitrite sau 1-nitropentane, Nytramil | 0,001 g | 0,001 g - 0,1 g |
| 182. | Methoxyphenamine/OMMA / C11H17NO / 1-(2-Methoxyphenyl)-N-methylpropan-2-amine sau 2-MMA; MPA; 2-MeO-MA; Orthoxine | 0,001 g | 0,001 g - 0,1 g"; |
e) în compartimentul III "Plante care conţin substanţe stupefiante sau psihotrope", în coloana a 2-a la poziţia 2 litera b), textul "plantă de cînepă (indiferent de faza de vegetaţie)" se substituie cu textul "plantă de canabis (cânepă) cu sau fără rădăcină sau părţi ale plantei care conţin tetrahidrocannabinol, indiferent de perioada de vegetaţie";
f) în note punctul 3 va avea următorul cuprins:
"3. Cantităţile mici, mari sau deosebit de mari de izomeri, stereoizomeri, eteri, esteri, analogi, metaboliţi, săruri (inclusiv sărurile izomerilor, stereoizomerilor, esterilor, analogilor şi metaboliţilor) ale substanţelor stupefiante sau psihotrope şi plante sau părţi ale acestora care conţin orice agent inclus în tabel corespund cantităţilor calculate de substanţe stupefiante sau psihotrope enumerate."
2. Prezenta hotărâre intră în vigoare la data publicării în Monitorul Oficial al Republicii Moldova.
| PRIM-MINISTRU | Dorin RECEAN |
Contrasemnează: |
|
| Ministrul afacerilor interne | Adrian Efros |
| Ministrul sănătăţii | Ala Nemerenco |
| Ministrul justiţiei | Veronica Mihailov-Moraru |
Nr.223. Chişinău, 26 martie 2024. |